Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

S
S. Apostolovska .	-	TREATMENT OF DIC AS A COMPLICATION OF POLYTRANSFUSION AT PATIENT WITH OBSTETRIC HEMORRHAGE-CASE REPORT
Saad I.M.	-	PROTHROMBIN AND FACTOR V LEIDEN GENE POLYMORPHISM IN PATIENTS WITH DVT
Saba N.	-	VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
Sabatier F.	-	ENDOTHELIAL MARKERS OF INJURY/REPAIR EQUILIBRIUM IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
	-	IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS
	-	SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS
Sabatino D.E.	-	SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
Sabin C.A.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
Sabino A.P.	-	LACK OF ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISM AND ATHEROMATOSIS EXTENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
	-	APO B ECORI AND INSERTION/DELETION POLYMORPHISMS IN BRAZILIAN YOUNG PATIENTS WITH ISQUEMIC STROKE
	-	PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE
	-	LIPOPROTEIN(A) IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD), ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE
	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
Sabovic M.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Sabri M.	-	EVALUATION FOR HYPERCOAGULOPATHY IN THALASSEMIA MAJOR PATIENTS IN ISFAHAN
Saccardi R.	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
Saccullo G.	-	PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
	-	ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
Sachais B.S.	-	THE COOPERATIVE ACTIVITY OF THE MIDDLE AND DISTAL CARBOXYL TERMINAL DOMAINS OF ADAMTS13 IS CRUCIAL FOR BINDING VON WILLEBRAND FACTOR UNDER FLOW
Sachs U.	-	HEPARIN INDEPENDENT ACTIVATION OF PLATELETS BY HIT ANTIBODIES. A COMMON OCCURRENCE
Sack M.	-	DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
Sadeghi H.	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
Sadeghian K.	-	COMBINED FACTOR V AND VIII DEFICIENCY, A LARGE GROUP FROM IRAN
Sadek I.	-	USE OF A CLINICAL ALGORITHM IN THE DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA
Sadekova O.N.	-	GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE
Sadler J.E.	-	THE FUNCTION OF VON WILLEBRAND FACTOR
Sadler J.	-	IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
Sadowski J.	-	C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Sáenz D.	-	EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
	-	EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
Sáez C.G.	-	INDUCTION OF TISSUE FACTOR ACTIVITY IN STIMULATED PLATELETS
Safa O.	-	THE SYNERGISTIC EFFECTS OF SYNTHETIC PHOSPHOLIPIDS AND RECOMBINANT TISSUE FACTOR IN THE OPTIMIZATION OF A PROTEIN S ASSAY SENSITIVITY
	-	THROMBOPATH KIT CORRELATES BETTER WITH FREE PROTEIN S TO PROTHROMBIN RATIO AND FUNCTIONAL PS THAN WITH FREE PS
	-	SELECTIVE ENHANCEMENT OF PROTEIN S REAGENT SENSITIVITY BY BOVINE GAMMA GLOBULIN
	-	PATIENTS WITH LUPUS ANTICOAGULANTS AND HISTORY OF THROMBOSIS CARRY ANTIBODIES TO BETA2-GLYCOPROTEIN I INHIBITING THE PHOSPHOLIPID OXIDATION-DEPENDENT ACTIVITY OF APC
Sage T.	-	TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Sage S.O.	-	A ROLE FOR DENSE GRANULE SECRETION IN POTENTIATION OF STORE-OPERATED CALCIUM ENTRY IN HUMAN PLATELETS
	-	ROLE OF TUBULIN-MICROTUBULES IN STORE-OPERATED CA2+ ENTRY IN HUMAN PLATELETS
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
	-	A ROLE FOR THE NA+/CA2+ EXCHANGER IN STORE-OPERATED CALCIUM ENTRY IN HUMAN PLATELETS
	-	A ROLE FOR TRPV1 IN THE ACTIVATION OF HUMAN PLATELETS
Saggau W.	-	FV LEIDEN, THE APOE GENOTYPE AND OTHER GENE POLYMORPHISMS IN PATIENTS UNDERGOING CARDIAC SURGERY
Saggiorato G.	-	EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
	-	ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
Sahni A.	-	FIBRINOGEN SYNTHESIZED BY CANCER CELLS AUGMENTS THE PROLIFERATIVE EFFECT OF FGF-2
Sahni S.K.	-	FIBRINOGEN SYNTHESIZED BY CANCER CELLS AUGMENTS THE PROLIFERATIVE EFFECT OF FGF-2
Sahud M.A.	-	IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS
Said J.	-	IDIOPATHIC FETAL GROWTH RESTRICTION (FGR) IS ASSOCIATED WITH DECREASED ANTICOAGULANT PROTEOGLYCAN DECORIN EXPRESSION IN HUMAN PLACENTA
Saile S.	-	THROMBIN GENERATION IN PATIENTS WITH HAEMOPHILIA AND VWD COMPARISON FLUORIMETRIC METHOD AND ROTEM
Sailer T.	-	ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE)
Saimovici J.	-	ASSESSMENT OF THE EFFECTIVENESS AND SECURITY OF HOME TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN IN ARGENTINA
Saint-Remy J.M.	-	ANTI-IDIOTYPIC ANTIBODIES FOR THE TREATMENT OF FACTOR VIII INHIBITORS
Saint-Remy J.	-	ACTIVATION OF HUMAN LUNG ENDOTHELIAL CELLS INDUCES THE RELEASE OF A FVIII STORAGE POOL
Saint-Remy J.M.	-	A LIMITED NUMBER OF ANTI-IDIOTYPIC ANTIBODIES NEUTRALIZE FVIII INHIBITORS AND RESTORE FULL FVIII ACTIVITY IN THE PLASMA OF HAEMOPHILIA PATIENTS
Saito J.	-	ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
Saito H.	-	ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
	-	DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
Saito J.	-	INCREASE IN NATTOKINASE ACTIVITY AND VITAMIN K2 CONTENT CAUSED BY DIPICOLINIC ACID
Saito H.	-	IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
Saito D.	-	THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Saito H.	-	THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Saitta M.	-	ANTIPHOSPHOLIPID ANTIBODY TESTING IN PIEMONTE AND VALLE D'AOSTA: A MULTILABORATORY EXTERNAL QUALITY ASSURANCE (EQA) PROGRAM
Sajadi S.	-	HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Sakai Y.	-	DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
Sakata Y.	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Sakata T.	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Sakata Y.	-	SILENCING OF A TARGETED PROTEIN IN IN VIVO PLATELETS USING A LENTIVIRAL VECTOR DELIVERING SHORT HAIRPIN RNA SEQUENCE
Sakata T.	-	AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
Sakata C.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Sakata Y.	-	INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Sakata T.	-	CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
Sakata Y.	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Sakellaropoulos G.	-	INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE
Sakizlis G.	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Sakly N.	-	PLASMA ANGIOGENIC ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
Sakon M.	-	INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Sakurai H.	-	DOES DIFFERENT D-DIMER LEVEL REDUCE THE USE OF VENOUS DUPLEX SCANNING TO RULE OUT DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM?
Sakurai J.	-	CLINICAL SIGNIFICANCE OF HMGB-1, SF AND PAI-1 AS A VITAL- PROGNOSIS MARKER
Sakurai H.	-	THE UTILITY OF QUANTITATIVE CALF MUSCLE NEARINFRARED SPECTROSCOPY IN THE FOLLOWUP OF ACUTE DEEP VEIN THROMBOSIS
	-	PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
Salaj P.	-	NEW HEREDITARY DYSFIBRINOGENEMIA AALPHA ASN106ASP ASSOCIATED WITH THROMBOSIS
	-	USE THROMBIN GENERATION ASSAY AND THROMBELASTOGRAPHY IN MONITORING OF RESPONSE TO DDAVP IN PATIENTS WITH TYPE 1 AND 2A VON WILLEBRAND DISEASE
	-	Detection of nonmuscle myosin-IIA, inclusions in neutrophils, D-variant of fibulin-1 and mutations within MYH9 gene in patients with MYH9-ralated disorders
	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Salazar D.E.	-	EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
Salces M.M.	-	SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
	-	PROPHYLAXIS WITH RECOMBINANT FVIIA
	-	ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
	-	PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
	-	NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
Salcioglu Z.	-	THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
	-	RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
	-	EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
	-	FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
Salem N.	-	DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Salem R.O.	-	EVALUATION OF A NEW, AUTOMATED QUANTITATIVE FACTOR XIII ASSAY
Salers P.	-	UNIQUE RECIPROCAL MAP KINASE REGULATION IN THROMBIN-INDUCED ENDOTHELIAL PRO-INFLAMMATORY ACTIVATION
Sales M.	-	NORMAL RANGE STUDY OF TOTAL HOMOCYSTEINE IN CITRATED AND EDTA PLASMA SAMPLES WITH A NEW TURBIDIMETRIC ASSAY ADAPTED TO AUTOMATED COAGULATION ANALYSERS
	-	PERFORMANCE OF A NEW TURBIDIMETRIC D-DIMER ASSAY ADAPTED TO AUTOMATED COAGULOMETERS
Salido G.M.	-	RELEVANCE OF CA2+ ENTRY TO PLATELET AGGREGATION BY ACTIVATION OF THROMBIN RECEPTORS
	-	REACTIVE OXYGEN SPECIES GENERATION IS REQUIRED FOR THROMBIN-INDUCED PLATELET APOPTOSIS
	-	A ROLE FOR SNAP-25 IN THROMBIN-INDUCED PLATELET AGGREGATION
Salifu M.O.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Saller F.	-	EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS)
Salles I.I.	-	FUNCTIONAL ANALYSIS OF HUMAN PLATELETS IN NOD/SCID MICE
Salles I.	-	THE VWF-GPIB AXIS AS A THERAPEUTIC TARGET
	-	NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
Salles I.I.	-	USE OF HAEMOPHILIA A ZEBRAFISH FOR SENSITIVE SCREENING AND CHARACTERISATION OF NOVEL PLATELET CANDIDATE GENES DERIVED FROM POST-GENOME STUDIES FOR PRO-THROMBOTIC FUNCTION
Salmistraro G.	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Salomon O.	-	TESTING AGONIST-INDUCED PLATELET AGGREGATION BY THE IMPACT-R
	-	FACTOR XI PHENOTYPE-GENOTYPE CORRELATIONS
	-	A DECREASED INCIDENCE RATE OF ISCHEMIC STROKE IN PATIENTS WITH SEVERE FACTOR XI DEFICIENCY SUGGESTS THAT THE DEFICIENCY CONFERS PROTECTION
Salomonsson A.C.	-	FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES
	-	FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
Saltykova N.B.	-	APOE GENE POLYMORPHISM CAN MODIFY THE RISK OF VENOUS THROMBOEMBOLISM
	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
Salvetti A.	-	BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
	-	EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM
Salvi A.	-	HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Salvi V.	-	THROMBOPHILIA AS A CAUSE OF UNEXPLAINED FETAL LOSS IN INDIAN PATIENTS AN IN DEPTH STUDY
Salvi A.	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Salviato R.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
Salvig J.D.	-	THROMBOPHILIA RISK FACTORS ARE ASSOCIATED WITH PREGNANCY RELATED THROMBOEMBOLISM
Samama M.M.	-	INHIBITION OF THROMBIN GENERATION BY IDRAPARINUX AND THE INFLUENCE OF RFVIIA
	-	THREE DIFFERENT PATTERNS OF CALIBRATED AUTOMATED THROMBOGRAM OBTAINED WITH HIRUDIN, MELAGATRAN, DABIGATRAN, ARGATROBAN, FONDAPARINUX AND DANAPAROD
	-	LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
	-	ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Samama M.	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Samama M.M.	-	UNFRACTIONATED HEPARIN MONITORING IN THE PRESENCE OF THE LONG-ACTING ANTI-XA AGENT IDRAPARINUX (SR34006): EFFECT OF EXOGENOUS ANTITHROMBIN
	-	IN VITRO SIMULATION OF BRIDGING THERAPY WITH LMWH AND VITAMIN K ANTAGONISTS. EFFECT ON THROMBIN GENERATION
	-	HYPERCOAGULABLE STATE IN MULTIPLE MYELOMA PATIENTS TREATED OR NOT WITH THALIDOMIDE
	-	THE EFFECT OF HIRUDIN ON THROMBIN GENERATION, APTT AND ECARIN CLOTTING TIME (ECT)
	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Samama M.	-	THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE
	-	D-DIMER MEASUREMENT AND THROMBOPHILIA SCREENING IN THE FOLLOW-UP OF PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Samama C.M.	-	ANTITHROMBOTIC THERAPY AND SURGERY
Samaya M.	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
Samel M.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Samiei S.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Samis J.A.	-	USE OF THROMBOELASTOGRAPHY TO DEFINE THE ROLE(S) OF NEUTROPHIL ELASTASE DURING NORMAL HAEMOSTASIS IN VITRO
	-	INACTIVATION OF ALPHA-1-PROTEASE INHIBITOR DURING CLINICAL SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IS NOT CONSISTENT WITH INHIBITOR POLYMERIZATION
Samladze P.	-	THE USE OF LOW-MOLECULAR HEPARIN IN PRAGNANTS
Samokhodskaya L.M.	-	GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE
Samor B.	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
	-	ANALYZE OF THE CO-PURIFIED PROTEINS WITH A HIGHLY PURIFIED PLASMA-DERIVED FACTOR VIII: FVIII-SD-35-15
Sampol J.	-	COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES
	-	VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
Samsami Z.	-	INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Samsonova N.N.	-	USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
Samuels N.	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
San Juan J.	-	ROLE OF 4G/5G PROMOTER POLYMORPHISM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OUTCOME OF SEPSIS
Sanak M.	-	THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN
	-	ASSOCIATION OF POLYMORPHIC SHORT TANDEM REPEAT -755 (CA)N IN THE HUMAN ALPHA2 INTEGRIN GENE PROMOTER WITH DEVELOPMENT AND EXTENT OF EARLY-ONSET CORONARY ARTERY DISEASE IN MEN: A CASE-CONTROL STUDY
Sanchez J.A.	-	A NOVEL HIGHLY PROMISING POINT-OF-CARE METHOD FOR HIV MONITORING
Sanchez T.	-	PERFORMANCE OF A NEW TURBIDIMETRIC D-DIMER ASSAY ADAPTED TO AUTOMATED COAGULOMETERS
Sánchez C.	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
Sánchez M.	-	DEFINITIVE PACEMAKER'S IN ANTICOAGULATED PATIENTS
Sanchez O.	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
Sánchez M.	-	ACUTE CORONARY SYNDROME AND MEAN PLATELET VOLUME
Sánchez I.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Sanchez O.	-	RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
Sanchez I.	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
Sánchez I.	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Sánchez J.	-	FACTOR XII-MEDIATED CONTACT ACTIVATION OCCURS ON THE SURFACE OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP)-ACTIVATED PLATELETS
Sánchez C.	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
Sanchez M.	-	CAN BLOOD HIPERVISCOSITY BE A PREDICTOR OF ACUTE CORONARY SYNDROME?
Sanchez S.	-	GENETIC THROMBOPHILIA AND THROMBOSIS OF CEREBRAL VENOUS SINUSES
Sanchez O.	-	LONG-TERM PROGNOSIS OF PULMONARY EMBOLISM
Sánchez Lázaro I.	-	INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS
	-	DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY
Sanchez-Blanco J.	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
Sánchez-Blanco J.J.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Sánchez-Luceros A.	-	MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
Sanchez-Luceros A.	-	AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Sánchez-Luceros A.	-	BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
Sanchez-Luceros A.	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
Sánchez-Luceros A.	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
Sanchez-Luceros A.	-	FACTOR XIII DEFICIENCY: SYMPTOMS, DIAGNOSIS AND LONG-TERM REPLACEMENT THERAPY
Sánchez-Luceros A.	-	EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
Sanchez-Luceros A.	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
	-	IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
Sánchez-Luceros A.	-	POISONING WITH SUPERWARFARIN
Sanchez-Martinez D.	-	ILPCA, A RECOMBINANT PC ACTIVATOR SUCCESSFULLY USED TO FORMULATE AN AUTOMATED PC CHROMOGENIC ASSAY IN LIQUID FORMAT
Sanda N.	-	FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
	-	MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Sandbaek G.	-	BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
Sandberg W.J.	-	ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Sandberg H.	-	A NOVEL RECOMBINANT B-DOMAIN-DELETED FACTOR VIII EXPRESSED IN A HUMAN CELL LINE
Sanders A.	-	WARFARIN PHARMACOGENOMICS: A MULTIPLEX METHOD FOR CYP2C9 AND VKORC1 GENOTYPING
Sandin M.	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
Sands M.	-	RETRIEVABLE INFERIOR VENA CAVA (IVC) FILTERS IN A TERTIARY CARE POPULATION
Sandset P.	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL DOSE HORMONE THERAPY, LOW DOSE HT, TIBOLONE AND RALOXIFENE ON C-REACTIVE PROTEIN AND OTHER INFLAMMATORY MARKERS
	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL AND LOW DOSE ORAL HORMONE THERAPY, TIBOLONE AND RALOXIFENE ON FUNCTIONALITY OF THE ACTIVATED PROTEIN C SYSTEM
Sandset P.M.	-	TISSUE FACTOR PATHWAY INHIBITOR (TFPI) POLYMORPHISMS, HORMONE REPLACEMENT THERAPY (HRT) AND RISK OF VENOUS THROMBOEMBOLISM (VTE)
	-	EXPRESSION OF THE TFPI V264M MUTANT IN VASCULAR CELL CULTURES INVOLVES STABILITY OF MRNA
	-	ACTIVATED COAGULATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
	-	FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
	-	CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS
	-	A CODING SNP AT THE GPI-ATTACHMENT SITE IN THE TFPI-BETA-SPECIFIC EXON IS ASSOCIATED WITH TFPI LEVELS
	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
Sandvik L.	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL DOSE HORMONE THERAPY, LOW DOSE HT, TIBOLONE AND RALOXIFENE ON C-REACTIVE PROTEIN AND OTHER INFLAMMATORY MARKERS
Sanford E.	-	AN ENU MUTAGENESIS SCREEN FOR DOMINANT GENETIC MODIFIERS OF THROMBOSIS IN THE FACTOR 5 LEIDEN MOUSE
Sanguigni V.	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
	-	LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX
	-	LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION
Sansilvestri-Morel P.	-	NOX4 IS STRONGLY INVOLVED IN ENDOTHELIAL PAI-1 SYNTHESIS
Santacroce R.R.S.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Santagostino E.	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
	-	ARTERIOVENOUS FISTULA (AVF) IS A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
	-	PORT IS NOT A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	POSTMARKETING SURVEILLANCE STUDY OF SUCROSE-FORMULATED RECOMBINANT FACTOR VIII FOR SEVERE HEMOPHILIA A: FINAL RESULTS
Santamaría A.	-	WHAT IS THE CLINICAL IMPACT OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DEFICIENCY?
	-	A RANDOMIZED, CONTROLLED, DOUBLE BLIND STUDY OF BEMIPARIN VS UNFRACTIONATED HEPARIN AS BRIDGING THERAPY OF ORAL ANTICOAGULATION THERAPY IN INVASIVE PROCEDURES OR AMBULATORY SURGERY. DESIGN OF THE BERTA STUDY
Santamaria A.	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
Santamaría A.	-	CLINICAL MANAGEMENT USING LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN PREGNANT WOMEN WITH THROMBOPHILIA, THROMBOEMBOLIC DISEASE (DVT) OR THROMBOPHILIA-RELATED MATERNOPLACENTAL SYNDROME: EXPERIENCE IN ONE CENTER
Santamaria A.	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Santaolaria M.	-	FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS
Santilli F.	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Santini A.	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
Santoro C.	-	PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
Santoro R.	-	VENOUS THROMBOSIS IN UNUSUAL SITES: A SINGLE INSTITUTION EXPERIENCE
Santos F.L.	-	FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION
Santos E.R.C.	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
Santos I.R.	-	FACTOR V LEIDEN AS A THROMBOPHILIA'S MARKER IN LIVER TRANSPLANTATION - AN EVALUATION
Santos C.G.M.	-	APO B ECORI AND INSERTION/DELETION POLYMORPHISMS IN BRAZILIAN YOUNG PATIENTS WITH ISQUEMIC STROKE
Santos M.V.	-	THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA)
Santos M.E.R.C.	-	PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND OTHER PARAMETERS INTERRELATED IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	RISK FACTORS ASSOCIATED TO THE DEVELOPMENT OF PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Santos A.B.	-	FIVE PROTHROMBOTIC POLYMORHISMS AND VENOUS THROMBOEMBOLISM
Santos M.T.	-	EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
	-	DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING
Santos M.E.R.C.	-	ASSOCIATION BETWEEN PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND SMOKING IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Santos T.	-	EPINEPHRINE REDUCES THE EFFECT OF ANTIPLATELET THERAPIES IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). ROLE OF PI3K
Santos M.T.	-	EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
Santos M.E.R.C.	-	HEMOSTATIC PROFILE IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD): ASSOCIATION TO ANKLE-BRACHIAL INDEX (ABI)
Santos M.T.	-	INSUFFICIENT INHIBITION OF PLATELET THROMBOXANE SYNTHESIS IS ASSOCIATED WITH GREATER CORONARY ARTERY DISEASE EVALUATED BY ANGIOGRAPHY
Santoso S.	-	HETEROGENEITY OF HPA-3 ALLOANTIBODIES: CONSEQUENCES FOR THE DIAGNOSIS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
	-	SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES
Sanzari M.	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
Saour J.	-	THE 4G/5G INSERTION/DELETION POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
Saperas E.	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Sapet C.	-	COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES
Saposnik B.	-	AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS
	-	RECOMBINATION IN ENDOTHELIAL CELL PROTEIN C RECEPTOR GENE PROCR. INFERENCE FOR THROMBOPHILIC PATIENTS SCREENING
	-	COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC
	-	THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING
	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
	-	ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY
Saracini C.	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
Saraeva R.	-	FREQUENCIES OF CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5, MDR1 ALLELIC VARIANTS IN PATIENTS WITH DIFFERENT ACENOCOUMAROL DOSE REQUIREMENTS
Sarantopoulos A.	-	SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
Sarasso C.	-	DEHYDROEPIANDROSTERONE INHIBITS PLATELET AGGREGATION
	-	EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
Sarig G.	-	COAGULATION PARAMETERS IN AMNIOTIC FLUID DURING HUMAN PREGNANCY ROLE OF TF AND TFPI
	-	ADAMTS-13 ACTIVITY, ANTIGEN AND INHIBITOR ANTIBODIES IN TTP PATIENTS A SINGLE CENTER EXPERIENCE
Sarkar R.	-	SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
Sarno M.M.S.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Sarode R.	-	EFFICACY OF WHOLE BLOOD PLATELET AGGREGATION IN THE EVALUATION OF BLEEDING OR THROMBOTIC TENDENCIES
	-	VARIATIONS IN PLATELET FUNCTION TEST OF NORMAL INDIVIDUALS MAY AFFECT TEST INTERPRETATIONS
Saronni L.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Sartorello F.	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
	-	POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Sartori R.	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
Sartori M.T.	-	ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
Sartori M.	-	EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
Sartori M.T.	-	INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
Sasanakul W.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
Sato K.	-	RELATIONSHIP BETWEEN THE DIAMETER OF SOLEUS VEIN AND D-DIMER
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
	-	PREVALENCE OF DEEP VENOUS THROMBOSIS OR PULMONARY EMBOLISM (DVT/PE) IN PSYCHIATRY PATIENTS
Sato Y.	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Sato K.	-	AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
Sato Y.	-	THE GENETIC ANALYSIS OF DEEP VEIN THROMBOSIS DURING PREGNANCY AND PERINATAL ASSOCIATED DISORDERS IN JAPANESE
Sato A.C.	-	EFFECT OF THE IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM PROPHYLAXIS GUIDELINE IN THE MANAGEMENT OF SURGICAL AND ORTHOPEDIC PATIENTS IN A PRIVATE TERTIARY HOSPITAL
Sato S.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Sato Y.	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Sato K.	-	PLASMA D-DIMER CORRELATES WITH AGE, CAROTID ARTERIAL OR THORACIC AORTIC ATHEROSCLEROSIS
Sato H.	-	G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN1 (GIT1) IS TYROSINE-PHOSPHORYLATED DOWNSTREAM OF INTEGRIN ALPHA IIB BETA3 IN PLATELETS
Satoh K.	-	A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
	-	EXTRACTS OF AN EDIBLE MUSHROOM WITH ANTITHROMBIN III-INDEPENDENT ANTICOAGULANT ACTIVITY
	-	SYNERGISM BETWEEN GI ACTIVATION AND CA2+ MOBILIZATION IN PLATELET THROMBOXANE A2 FORMATION
	-	PLATELET ADHESION TO LAMININ IS MEDIATED THROUGH VON WILLEBRAND FACTOR AND GLYCOPROTEIN IB UNDER HIGH SHEAR FLOW
Satoskar P.	-	THROMBOPHILIA AS A CAUSE OF UNEXPLAINED FETAL LOSS IN INDIAN PATIENTS AN IN DEPTH STUDY
Satta N.	-	ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES
	-	DIFFERENCES IN ENDOTHELIAL CELL ACTIVATION BY IGG FROM PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME OR WITH IMMUNE THROMBOCYTOPENIC PURPURA
Sauger A.	-	ANALYZE OF THE CO-PURIFIED PROTEINS WITH A HIGHLY PURIFIED PLASMA-DERIVED FACTOR VIII: FVIII-SD-35-15
Saut N.	-	CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
	-	PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Sautiere K.	-	METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES
Savanelli M.C.	-	LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY
Savchuk A.N.	-	ISOLATION AND CHARACTERIZATION OF PLASMINOGEN-ACTIVATING PROTEINASE FROM AGKISTRODON HALYS HALYS VENOM
Savchuk O.M.	-	THE NOVEL PROTEIN-PROTEIN INTERACTION IN MAMMALIAN HAEMOSTASIS SYSTEM INDUCING BY STREPTOKINASE
	-	EFFECTS OF 7 KDA STREPTOKINASE FRAGMENT ON THE RABBIT HAEMOSTASIS SYSTEM
Savchuk A.N.	-	ISOLATION AND CHARACTERIZATION OF PLASMINOGEN-ACTIVATING PROTEINASE FROM AGKISTRODON HALYS HALYS VENOM
Savi P.	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
	-	SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS
	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
Savic S.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Savidge G.F.	-	THROMBIN GENERATION ASSAY: CLINICAL USE IN MONITORING FVIII BYPASSING AGENT THERAPY DURING SURGERY IN A SEVERE HAEMOPHILIA A PATIENT WITH INHIBITOR
	-	THE FIRST CAUSATIVE MUTATION OF HAEMOPHILIA A IDENTIFIED IN THE PROMOTER REGION OF THE FACTOR VIII GENE (F8)
Savion N.	-	PLATELETS AND SUBENDOTHELIAL MATRIX PROTEINS DIFFERENTIALLY SUPPORT ADHESION OF LYMPHOCYTE SUBPOPULATIONS UNDER ARTERIAL SHEAR STRESS
	-	TESTING AGONIST-INDUCED PLATELET AGGREGATION BY THE IMPACT-R
	-	CLOPIDOGREL UNRESPONSIVENESS OVERCOME BY RELOADING: ASSESSEMENT BY PLATELET AGGREGOMETRY AND IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	RESPONSIVENESS TO CLOPIDOGREL AND ASPIRIN AMONG PATIENTS WITH ACUTE CORONARY SYNDROME AS ASSESSED BY THE IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	PLATELET GPIIBIIIA-FIBRINOGEN BINDING ACTIVITY IS INCREASED BY ALLICIN (A THIOL-REACTIVE REAGENT)
Savoia A.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Savonarola A.	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Savory M.	-	COAGULATION STUDIES IN PATIENTS PRESENTING WITH HYPOTHERMIA
Savushkin A.V.	-	CLOTTING IN THE STREAM: NONTHROMBOCYTE PLASMA
	-	PHENOMENON OF THE STRENGTHENING OF THE CLOT AFTER ITS STRETCHING DESTRUCTION: NONTHROMBOCYTE PLASMA
Savushkin A.	-	THE CLINICAL RELEVANCE OF PLATELET HETEROGENEITY AND ACTIVATION IN PATIENT WITH ANTIPHOSPHOLIPID SYNDROME
Savushkin A.V.	-	THROMBIN CONCENTRATION AND PERMEABILITY OF FIBRIN CLOT
	-	THROMBOCYTE RETRACTION HAS NOT INFLUENCE ON BLOOD CLOT DEFORMABILITY
	-	HYDRAULIC FIRMNESS OF NATIVE CLOT IN HUMAN VESSEL: MODEL EXPERIMENTS
	-	TENSILE STRENGTH OF THE NATIVE BLOOD CLOTS
Sawiah S.	-	IS TODAY'S THROMBOPHILIA PROFILE ADEQUATE IN IDENTIFYING A POSSIBLE CAUSE FOR RECURRENT FETAL LOSS IN WOMEN?
Sawicki Z.	-	EXPRESSION OF TISSUE FACTOR (TF), FACTOR X, PROTHROMBIN FRAGMENT 1+2 (F 1+2) AND FIBRIN IN BREAST CANCER: COMPARISON BETWEEN PRIMARY TUMOR AND METASTATIC LESIONS IN REGIONAL LYMPH NODES
Sax F.	-	THE PTT IS NOT ENOUGH PREOPERATIVE COAGULATION SCREENING IN CHILDREN
Saxena R.	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
Saydam G.	-	RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Sayed M.	-	TRITON X-100 IS RESPONSIBLE FOR THE LOSS OF ALPHA2-ANTIPLASMIN INHIBITORY ACTIVITY IN SOLVENT-DETERGENT TREATED PLASMA
Sayilan Sen H.H.S.	-	FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
	-	EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
	-	THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
Sayli T.R.	-	LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Sbrighi S.	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
Scaldaferri F.	-	EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS
Scalone L.	-	PREFERENCES TOWARDS COAGULATION FACTOR CONCENTRATES USED TO TREAT HEMOPHILIC PATIENTS WITH INHIBITORS: THE PATIENTS', PHYSICIANS' AND PHARMACISTS' PERSPECTIVE
Scanavini D.	-	ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
Scandellari R.	-	HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME
	-	VENOUS THROMBOSIS DURING ORAL CONTRACEPTION IN NORMAL OR THROMBOPHILIC WOMEN WHO HAD REMAINED ASYMPTOMATIC DURING PAST PREGNANCIES
	-	MYOCARDIAL INFARCTION AFTER OVARIAN STIMULATION FOR INFERTILITY MANAGEMENT
	-	RETINAL CENTRAL ARTERY OCCLUSION AFTER 10 PILLS OF DROSPIRENONE CONTAINING PREPARATION (YASMIN)
Scapin M.	-	MYOCARDIAL INFARCTION AFTER OVARIAN STIMULATION FOR INFERTILITY MANAGEMENT
	-	THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES
	-	HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME
	-	THREE NEW MUTATIONS IN FXII DEFICIENCY
Scapoli G.L.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Scarabin C.	-	SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS
Scaraggi F.A.	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
Scaraggi A.	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
Scaraggi F.A.	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
Scarano L.	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
Scarno A.	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Scaroni C.	-	POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
Scarparo P.	-	THREE NEW MUTATIONS IN FXII DEFICIENCY
	-	RETINAL CENTRAL ARTERY OCCLUSION AFTER 10 PILLS OF DROSPIRENONE CONTAINING PREPARATION (YASMIN)
	-	THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENT WITH LOW ADAMTS-13 ACTIVITY LEVELS BUT NO INHIBITORY AUTOANTIBODIES
	-	HOMOZYGOUS FOUR-BASE DELETION TGAG IN THE GLYCOPROTEIN IBA CODING SEQUENCE LEADING TO A PREMATURE STOP CODON IN A PATIENT WITH BERNARD-SOULIER SYNDROME
Scarvelis D.	-	SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
	-	DEFINING BENEFIT-RISK TRADEOFF VALUES FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
Schaap M.C.L.	-	MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE
	-	CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY
Schaefer A.	-	HIGH INCIDENCE OF CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE A REAL WORLD SITUATION
Schaeffer P.	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
Schaeffer L.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Schaeffer-Reiss C.	-	IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
Schäfer W.	-	AN INTEGRATED APPROACH TO EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED VWF/FVIII CONCENTRATE
	-	EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED PROTHROMBIN COMPLEX CONCENTRATE THROUGH MULTIPLE DEDICATED MEASURES
Schäfer A.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
Schäfer W.	-	ADDITION OF PRION REDUCTION FACTORS FROM SINGLE STEP EXPERIMENTS MAY OVERESTIMATE MANUFACTURING PROCESS CLEARANCE CAPABILITY
Schäfer A.	-	THE CHEMOKINE FRACTALKINE MEDIATES LEUKOCYTE RECRUITMENT TO INFLAMMATORY ENDOTHELIUM AT ARTERIAL SHEAR RATES IN VIVO AND IN VITRO
Schalkwijk C.G.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
Schalkwijk C.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Schambeck C.M.	-	ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
Schapkaitz E.	-	DELAYED HYPERSENSITIY TO LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN PREGNANCY
Scharf R.E.	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
	-	RISK STRATIFICATION OF RECURRENT VENOUS THROMBOEMBOLISM
	-	INTERACTION BETWEEN ORAL CONTRACEPTIVE USE AND COAGULATION FACTOR LEVELS IN DEEP VEIN THROMBOSIS
	-	LONGTERM PROPHYLACTIC TREATMENT WITH RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN SEVERE CONGENITAL FACTOR VII DEFICIENT PATIENTS
Scharf C.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Scharf R.E.	-	RISK DETERMINANTS OF ARTERIAL THROMBOSIS INCREASE THE RISK OF INTRAUTERINE GROWTH RESTRICTION (IGR)
	-	RISK DETERMINANTS OF NONARTERITIC ISCHEMIC OPTIC NEUROPATHY (NAION)
	-	FONDAPARINUX IS A SAFE AND EFFECTIVE ALTERNATIVE ANTICOAGULANT IN PREGNANT WOMEN WITH INTOLERANCE TO LOW-MOLECULAR- WEIGHT HEPARINS AND HEPARINOIDS
	-	RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN A SUBSEQUENT PREGNANCY IN WOMEN WITH A FIRST HISTORY OF VENOUS THROMBOSIS
	-	INCREASED PLASMINOGEN ACTIVITY IS AN INDEPENDENT PREDICTOR OF BLEEDING IN HEMOPHILIACS
	-	SUCCESSFUL USE OF RECOMBINANT FACTOR VIIA (RFVIIA, NOVOSEVEN) IN TWO PATIENTS WITH BERNARD SOULIER SYNDROME AND DENTAL EXTRACTION
	-	LONGTERM PROPHYLACTIC TREATMENT WITH FACTOR IX P IN A PATIENT WITH SEVERE CONGENITAL FACTOR X DEFICIENCY
	-	CLINICAL EXPERIENCE WITH FACTOR VIII/VON-WILLEBRAND-FACTOR CONCENTRATE HAEMATE P RESULTS ON EFFICACY AND SAFETY IN A SINGLE CENTRE REGISTRY
Scharling B.	-	EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF A RAPID-ACTING RECOMBINANT FVII ANALOGUE, NN1731, IN HEALTHY MALE SUBJECTS
Scharnagl H.	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Scharrer I.	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
	-	FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
	-	MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE
	-	DATABASE MANAGEMENT SYSTEM FOR A HAEMOPHILIA COMPREHENSIVE CARE CENTRE
	-	RAPID INCREASE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HAEMOPHILIA AND CHRONIC HCV- INFECTION
	-	THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS
	-	BLEEDING COMPLICATIONS IN SURGICAL PATIENTS WITH VON WILLEBRAND'S DISEASE
Schattner M.	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
	-	DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
	-	IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
Schaub R.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Schechter T.	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
Schedel A.	-	DOPAMINE IS A COACTIVATOR FOR PLATELET ADHESION TO COLLAGEN AND ACTS VIA D2-LIKE RECEPTORS
Scheffer H.	-	ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH
Scheiflinger F.	-	MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
	-	IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Scheinichen D.	-	EFFECTS OF FIBRINOGEN LEVELS AND CLOT STRENGTH IN THE PRESENCE OF THROMBOCYTOPENIA
Scheinig D.	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
Schelin A.	-	CHAOTIC ADVECTION IN STENOSED ARTERIES
Schellong S.	-	THE ANTICOAGULANT PROTEINS S AND ANTITHROMBIN DISPLAY REMARKABLE SEX-DEPENDENT CHANGES DURING AGING
Schellong S.M.	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
	-	LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
Schellong S.S.M.S.	-	RESULTS OF A ONE-YEAR REGISTRY OF BLEEDING COMPLICATIONS OF VITAMIN K ANTAGONIST THERAPY OUTSIDE A CONTROLLED POPULATION
Schellong S.	-	CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
	-	INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
	-	HIT II-INDUCED CRITICAL LIMB ISCHAEMIA TREATED WITH UROKINASE AND ARGATROBAN
Schellong S.M.	-	EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
	-	DISTAL DVT: WORTH DIAGNOSING? YES
Scherrmann J.	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
	-	A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
Schiavoni M.	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
Schiavulli M.	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
Schiemann M.	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
Schiff E.	-	HIGH PROPORTION OF MATERNAL THROMBOPHILIA AMONG PREVIOUSLY UNEXPLAINED STILLBIRTH CASES
	-	PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA
Schijvenaars M.	-	ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH
Schinco P.	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
Schinco P.C.	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
Schindewolf M.	-	USE OF FONDAPARINUX IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II
	-	ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS?
	-	MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM
	-	ALTERNATIVE ANTICOAGULATION WITH FONDAPARINUX IN PREGNANT PATIENTS WITH HEPARIN-INTOLERANCE
	-	ALTERNATIVE ANTICOAGULATION WITH DANAPAROID IN TWO PREGNANCIES IN A PATIENT WITH FORMER HIT, THROMBOPHILIA, A HISTORY OF VENOUS THROMBOSIS AND RECURRENT PREGNANCY LOSSES
	-	ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
	-	CUTANEOUS DELAYED-TYPE IV-HYPERSENSITIVITY REACTION (DTH) TO HEPARIN AND HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II (HIT) IS THERE AN ASSOCIATION ?
Schlachterman A.	-	IN VIVO EFFECTS OF MURINE AND HUMAN APC
Schlammadinger A.	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION TREATMENT OF THERAPY-RESISTENT ACQUIRED HAEMOPHILIA WITH HIGH INHIBITOR TITER: A CASE REPORT
	-	COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME?
	-	LOW DOSE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE PROPHYLAXIS OF A PATIENT WITH ACQUIRED HAEMOPHILIA AFTER UNSUCCESSFUL ERADICATION THERAPY
	-	THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA
Schlegel N.	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
	-	PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Schlembach D.	-	THROMBIN GENERATION IN NORMAL UNCOMPLICATED PREGNANCY
Schlichter A.	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
Schliemann C.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Schloss P.	-	DOPAMINE IS A COACTIVATOR FOR PLATELET ADHESION TO COLLAGEN AND ACTS VIA D2-LIKE RECEPTORS
Schluga P.	-	VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
Schmaier A.H.	-	SCUPA OR FXII STIMULATE ERK1/2 OR AKT THROUGH UPAR AND BETA 1 INTEGRINS
	-	THROMBOSTATIN FM19 - A THROMBIN RECEPTOR ACTIVATION ANTAGONIST
Schmid P.	-	PHARMACOKINETICS OF DALTEPARIN IN PROPHYLACTIC DOSAGE IN PATIENTS WITH IMPAIRED RENAL FUNCTION
	-	PLATELET RESPONSE DOES NOT CHANGE DURING LONG-TERM-TREATMENT (8YEARS) WITH 50 OR 100 MG ACETYLSALICYLIC ACID (ASA) FOR SECONDARY PREVENTION
Schmidt T.	-	PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
Schmidt E.B.	-	TEST OF ASPIRIN RESISTANCE
Schmidt T.	-	PRION PROTEIN (PRPSC) REMOVAL BY CHROMATOGRAPHY PURIFICATION AND NANOFILTRATION OF FIXS AND PCC
Schmidt H.	-	ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
Schmidt E.B.	-	RESPONSE TO ASPIRIN AND CLOPIDOGREL IN HEALTHY MEN
Schmidt H.	-	ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
Schmidt-Woell T.	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
Schmoll H.J.	-	PLASMA CONCENTRATIONS OF TISSUE FACTOR AND COAGULATION FACTOR XIIA IN PREGNANT WOMEN
	-	THERAPY OF ACQUIRED HEMOPHILIA HAS CYTOTOXIC AND RITUXIMAB TREATMENT TO BE COMBINED WITH IMMUNOADSORPTION?
Schmugge M.	-	PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY
	-	SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS
Schnee J.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
	-	THE ORAL DIRECT THROMBIN INHIBITOR, DABIGATRAN ETEXILATE, IS EFFECTIVE AND SAFE FOR PREVENTION OF MAJOR VENOUS THROMBOEMBOLISM FOLLOWING MAJOR ORTHOPEDIC SURGERY
	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Schneider S.	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
Schneider H.	-	BREAKPOINT CHARACTERIZATION IN HEMOPHILIA PATIENTS WITH LARGE DELETIONS IN THE FVIII GENE REVEALS INVOLVEMENT OF VARIOUS MUTATION MECHANISMS
Schneider K.	-	IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
Schneppenheim R.	-	THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Schnider T.	-	EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Schnitzer J.E.	-	VASCULAR PROTEOMIC MAPPING IN VIVO
Schnog J.B.	-	ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
Schobess R.	-	EFFECTS OF THE FACTOR V G1691A MUTATION AND THE FACTOR II G20210A VARIANT ON THE CLINICAL EXPRESSION OF SEVERE HEMOPHILIA A ( 1%) IN CHILDREN
Schoebess R.	-	THROMBIN GENERATION IN PATIENTS WITH HAEMOPHILIA AND VWD COMPARISON FLUORIMETRIC METHOD AND ROTEM
Schoedon G.	-	TRANSCRIPTOME ANALYSIS OF THE PAR-1 MEDIATED ACTIVATION PATHWAY IN HUMAN MONOCYTES AND INTERACTIONS OF ACTIVATED PROTEIN C
Schoenfisch M.H.	-	ANALYSIS OF AFFINITY OF KNOB-HOLE INTERACTIONS RESPONSIBLE FOR FIBRIN POLYMERIZATION
Schoenwaelder S.M.	-	SELECTIVE SIGNALLING ROLE FOR PI 3-KINASE P110BETA IN THROMBIN-INDUCED CLOT RETRACTION
	-	HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
	-	THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
Schols S.E.M.	-	DETECTION OF ANTI-HAEMOSTATIC EFFECT OF PLASMA DILUTION VIA THROMBIN GENERATION
Scholten T.	-	PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Scholz T.	-	THROMBIN-INDUCED INTERLEUKIN 1BETA SYNTHESIS IN PLATELET SUSPENSIONS: IMPACT OF CONTAMINATING LEUKOCYTES
	-	TESTING FVIIA EFFICACY AS A POTENTIAL TREATMENT FOR PATIENTS WITH HERMANSKY-PUDLAK-SYNDROME TYPE 1 (HPS-1) WITH A THROMBIN GENERATION TEST (TGT) IN TWO CASES
Scholz U.	-	THROMBIN GENERATION IN PATIENTS WITH THROMBOPHILIA OR THROMBOSIS AND PREGNANCY
	-	PLATELET FUNCTION IN IMMUNE THROMBOCYTOPENIA (M. WERLHOF)
	-	MONITORING AND THERAPY OF SEVERE ANTITHROMBIN DEFICIENCY IN PREGNANT WOMEN
Scholz T.	-	EFFECT OF RFVIIA (NOVOSEVEN,) AND FEIBA (FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY) ON ANTICOAGULANT-INDUCED INHIBITION OF THROMBIN GENERATION IN PLATELET-RICH PLASMA (PRP)
Scholz U.	-	THROMBIN GENERATION IN PATIENTS WITH HAEMOPHILIA AND VWD COMPARISON FLUORIMETRIC METHOD AND ROTEM
	-	THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Schömig E.	-	IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Schöni R.	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Schoormans S.C.M.	-	TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE
Schöpp C.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
Schorer R.	-	FLUVASTATIN INHIBITS REGULATED SECRETION OF ENDOTHELIAL CELL VON WILLEBRAND FACTOR IN RESPONSE TO DIVERSE SECRETAGOGUES
Schouten M.	-	ENDOGENOUS PROTEIN C INHIBITS PULMONARY COAGULATION BUT FACILITATES BACTERIAL DISSEMINATION IN THE EARLY PHASE OF PNEUMOCOCCAL PNEUMONIA IN MICE
Schouten J.	-	THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER
Schouten M.	-	FACTOR XIII IS AN IMPORTANT MEDIATOR IN THE COAGULATING PLASMA INDUCED IL-8 PRODUCTION BY HUMAN LUNG EPITHELIAL CELLS
Schramm W.	-	EFFECT OF VARIATIONS OF SINGLE FACTOR ACTIVITY ON THROMBIN GENERATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST
	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
	-	INFLUENCE OF FV LEIDEN ON THE KINETICS OF THROMBIN FORMATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST (TDT)
Schreijer A.J.M.	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
	-	PREVENTION OF TRAVELLERS' THROMBOSIS: A COMPARISON OF THREE INTERVENTIONS THAT PROMOTE VENOUS OUTFLOW
	-	THE EFFECT OF FLIGHT-RELATED BEHAVIOUR ON THE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL
	-	AIR TRAVEL AND VENOUS THROMBOSIS: A SYSTEMATIC REVIEW
Schrevel M.	-	PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
Schröder J.	-	BREAKPOINT CHARACTERIZATION IN HEMOPHILIA PATIENTS WITH LARGE DELETIONS IN THE FVIII GENE REVEALS INVOLVEMENT OF VARIOUS MUTATION MECHANISMS
Schroder M.	-	OLIGOSACCHARIDES FROM DIFFERENT LOW MOLECULAR WEIGHT HEPARINS HAVE DIFFERENT ANTICOAGULANT AND PROTAMINE SULPHATE NEUTRALIZATION PROFILES
Schroeder M.	-	RENAL ELIMINATION OF TINZAPARIN VERSUS ENOXAPARIN IN NORMAL VERSUS NEPHRECTOMIZED RATS
Schroeder V.	-	IS HETEROZYGOUS FACTOR XIII DEFICIENCY ASSOCIATED WITH PREGNANCY LOSS? A CASE REPORT
	-	DEVELOPMENT OF MONOCLONAL ANTIBODIES FOR DIRECT DETECTION OF FACTOR XIII ACTIVATION PEPTIDE IN PLASMA
Schroth P.	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION
	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT
Schubert P.	-	APPLICATION OF PROTEOMICS TO THE IDENTIFICATION OF PROTEINS ASSOCIATED WITH THE PLATELET STORAGE LESION AND THEIR TRANSLATION
Schuehly U.	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Schuepbach R.A.	-	ROLE OF PAR1 IN PROTECTIVE SIGNALING BY ACTIVATED PROTEIN C IN SYSTEMIC INFLAMMATION
	-	ACTIVATED PROTEIN C LEADS TO CELL SURFACE ACCUMULATION OF CLEAVED PAR1 AND SUPPORTS PROTECTIVE SIGNALING EVEN IN THE PRESENCE OF THROMBIN
Schuettrumpf J.	-	IN VIVO EFFECTS OF MURINE AND HUMAN APC
	-	PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
	-	NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
Schuetze B.	-	MANAGEMENT OF SEVERE PULMONARY EMBOLISM IN A PATIENT WITH HOMOZYGOUS PROTEIN C DEFICIENCY
Schulman S.	-	CONTROVERSIES IN THE TREATMENT OF THE ANTIPHOSPHOLIPID SYNDROME
	-	CLINICAL FACTORS INFLUENCING RETURN TO NORMAL HEMOSTASIS AFTER STOPPING WARFARIN
	-	CLINICAL FACTORS INFLUENCING THE SENSITIVITY TO WARFARIN WHEN RESTARTED AFTER SURGERY
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS
	-	THE RISK OF FATAL PULMONARY EMBOLISM AFTER STOPPING ANTICOAGULANT THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLISM
	-	LABORATORY EVIDENCE OF HYPERFIBRINOLYSIS IN ASSOCIATION WITH LOW PAI-1 ACTIVITY
	-	THE EXPRESSION OF PLATELET RECEPTORS AND MARKERS OF PLATELET ACTIVATION IN PATIENTS WITH HEMOPHILIA A AND VON WILLEBRANDS DISEASE
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Schulte S.	-	CHARACTERIZATION OF COMMERCIALLY AVAILABLE VWF-CONTAINING FVIII CONCENTRATES BY VWF MULTIMER ANALYSIS
Schultheiss H.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Schulz C.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
	-	IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB
	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
	-	THE CHEMOKINE FRACTALKINE MEDIATES LEUKOCYTE RECRUITMENT TO INFLAMMATORY ENDOTHELIUM AT ARTERIAL SHEAR RATES IN VIVO AND IN VITRO
Schulze H.	-	AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
Schumacher W.A.	-	CLOPIDOGREL PRODUCES DISTINCT DOSE-RESPONSE RELATIONSHIPS FOR INHIBITION OF PLATELET AGGREGATION (IPA) AND ANTITHROMBOTIC EFFICACY MEASURED IN RATS AND RABBITS
Schumock G.T.	-	EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
Schunemann H.	-	STUDY DESIGN, QUALITY OF EVIDENCE AND GUIDELINES
Schürgers L.J.	-	CIRCULATING MATRIX GLA PROTEIN: A POTENTIAL MARKER FOR VASCULAR COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
Schurgers L.J.	-	Circulating inactive human Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular disease
Schürzinger K.	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
	-	IN VIVO ASSESSMENT OF EXPERIMENTAL MELANOMA METASTASIS BY INTRAVITAL MICROSCOPY REVEALS A CRITICAL ROLE OF PLATELETS AND GLYCOPROTEIN IIB
Schutgens R.E.G.	-	EVALUATION OF TWO SOLUBLE FIBRIN MONOMER ASSAYS
	-	THE CLINICAL VALIDATION OF A NEW QUANTITATIVE HIGH SENSITIVE D-DIMER ASSAY
	-	THE USE OF THE ENDOGENOUS THROMBIN POTENTIAL ASSAY IN THE DIAGNOSIS OF DEEP VENOUS THROMBOSIS
Schüttler W.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
Schützer K.M.	-	EFFECT OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 ON GLOMERULAR FILTRATION RATE IN ELDERLY HEALTHY SUBJECTS
Schved J.F.	-	CLINICAL PHENOTYPES AND FACTOR VII GENOTYPE IN CONGENITAL FACTOR VII DEFICIENCY
Schved J.	-	ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
	-	INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY
	-	GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
	-	INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
Schved S.J.F.	-	ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS RYTHMATOSUS
Schwabe D.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Schwarz M.	-	CONFORMATION-SPECIFIC BLOCKADE OF THE INTEGRIN GPIIB/IIIA): IN VITRO AND IN VIVO RESULTS DEMONSTRATING A SELECTIVE PLATELET BLOCKADE WITH LESS ADVERSE EFFECTS
Schwarz T.	-	THE ANTICOAGULANT PROTEINS S AND ANTITHROMBIN DISPLAY REMARKABLE SEX-DEPENDENT CHANGES DURING AGING
Schwarz H.P.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
	-	PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
Schwarz M.	-	A NOVEL SINGLE-CHAIN (SCFV) ANTIBODY PHAGE-DISPLAY STRATEGY FOR THE DEVELOPMENT OF POTENTIAL ANTI-ATHEROSCLEROTIC DRUGS
Schwarz H.P.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
	-	PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY
Schwarz M.	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
	-	SPECIFIC AND SENSITIVE DETECTION OF THE INHIBITION OF THE PLATELET P2Y12-RECEPTOR WITH THE PFA-100 SYSTEM USING A NEW CARTRIDGE DESIGN
Schweiger M.J.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Schwetz N.	-	IMPROVING COMMUNICATION AND SUPPORTING EFFICIENT PRODUCT USE WITH ELECTRONIC RECORDING
Schwieler J.	-	ASSESSMENT OF THE ELECTROPHYSIOLOGICAL EFFECTS OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN SUBJECTS UNDERGOING AN INVASIVE ELECTROPHYSIOLOGICAL PROCEDURE
Schwonberg J.	-	NON-RESPONSE TO ASPIRIN (ASA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	NON-RESPONSE TO CLOPIDOGREL IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	DETERMINATION OF CLOPIDOGREL MAIN METABOLITE IN PLASMA USEFUL TOOL FOR THERAPY MONITORING ?
Sciartilli A.	-	SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY
	-	INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
Sciuccati G.B.	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
	-	TYPE 2B VON WILLEBRAND'S DISEASE. REPORT FROM A SINGLE CENTER IN ARGENTINA
	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
Scoditti E.	-	HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
	-	HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS
	-	THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1
	-	THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION
Scognamiglio F.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Scott E.M.	-	ALANINE AMINOTRANSFERASE, ATHEROTHROMBOTIC RISK FACTORS AND METABOLIC SYNDROME IN SOUTH ASIANS
Scriven N.	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Scroyen I.	-	DEFICIENCY OF PLASMINOGEN ACTIVATOR INHIBITOR-2 IMPAIRS NUTRITIONALLY INDUCED MURINE ADIPOSE TISSUE DEVELOPMENT
Scuderi P.	-	IMPORTANCE OF FIBRIN BINDING FOR THERAPEUTIC EFFICACY OF DIRECT THROMBOLYTICS
Scudla V.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Scull J.	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Scully M.	-	DENDROASPIN, AN RGD-CONTAINING SNAKE VENOM PROTEIN INITIATES ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A2-ALPHA ACTIVATION
	-	RGD-CONTAINING DENDROASPIN, RGD PEPTIDE AND DDM PEPTIDE INDUCE APOPTOSIS OF JURKAT CELLS
	-	DETERMINATION OF THE INTEGRIN BINDING PROPERTIES OF THE PUTATIVE INTEGRIN-BINDING MOTIFS OF ADAM PROTEINS USING MUTANTS BASED UPON A DENDROASPIN SCAFFOLD
Scully M.F.	-	SYNERGISTIC EFFECT OF HEPARIN, LOW MOLECULAR WEIGHT HEPARIN AND PACLITAXEL ON CYTOTOXICITY FOR BREAST CARCINOMA CELLS IN CULTURE
Scully M.	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
	-	FXI/ADAMTS13 COMPLEX IN PLASMA
	-	BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
Scully M.F.	-	MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS HEPARIN SENSITIVE PEAKS IN THE SERUM PEPTIDOME OF NORMAL HEALTHY INDIVIDUALS
	-	MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS PEAKS ARE DIFFERENT IN THE SERUM PEPTIDOME IN COMPARISON TO THE PLASMA PEPTIDOME
	-	SEX DIFFERENCE IN PLASMA SENSITIVITY TO TISSUE FACTOR RELATES TO THE LEVELS OF CIRCULATING PLATELET-DERIVED MICROPARTICLES
	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC BLOOD BASED APPROACH
Scully M.	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
Scully M.F.	-	AT LOW CONCENTRATIONS OF TISSUE FACTOR, CIRCULATING MICROPARTICLES CAUSE A MARKED SHORTENING OF THE RECALCIFICATION TIMES OF PLASMA FROM NORMAL HEALTHY INDIVIDUALS
Scully M.	-	ADAMTS 13 IN NON-THROMBOTIC THROMBOCYTOPENIC PURPURA CONDITIONS
	-	INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
Scully M.F.	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC CELL-BASED APPROACH
	-	THE INHIBITORY ACTIVITY OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ON BREAST CARCINOMA CELL LINES
Scully M.	-	SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
Scully M.F.	-	HEPARIN TREATMENT INCREASES TYROSINE PHOSPHORYLATION OF PROTEINS IN BREAST CANCER CELLS: DIFFERENCES IN THE EFFECT OF LMWH AND UFH
Scully M.	-	SELECTIVE BINDING TO INTEGRIN ALPHA-9-INTEGRIN EXPRESSING CELLS OF MUTANTS OF DISINTEGRIN-LIKE DOMAIN OF ADAM-15 CONTAINING THE PUTATIVE INTEGRIN BINDING MOTIF OF ADAM-2, -12 AND -19, RESPECTIVELY
Scurati S.	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
Sealey F.	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Seaton B.A.	-	CRYSTAL STRUCTURE OF THE C2 DOMAIN OF LACTADHERIN
Sebaoun D.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
Sedano C.	-	RITUXIMAB TREATMENT FOR MILD HEMOPHILIA A WITH INHIBITORS
Sedding D.	-	FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS
Sedding D.G.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Sedding D.	-	THE UROKINASE SYSTEM REGULATES THE MOBILIZATION, HOMING AND DIFFERENTIATION OF PROGENITOR CELLS INTO ENDOTHELIAL CELLS
Sedding D.G.	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
Seecharan J.	-	HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Seehafer T.	-	HAPLOTYPES OF THE PROTEIN Z GENE ASSOCIATED WITH SYMPTOMATIC THROMBOEMBOLISM IN CHILDREN
Seesing T.H.	-	IMPAIRED EFFICACY OF CLOPIDOGREL IN PATIENTS WITH A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Segal H.	-	LACK OF PREDICTIVE VALUE OF HIGH SHEAR PLATELET FUNCTION IN A POPULATION BASED COHORT STUDY OF ACUTE VASCULAR EVENTS
Segal H.C.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
Segendorf H.	-	RISK STRATIFICATION OF RECURRENT VENOUS THROMBOEMBOLISM
Segers K.	-	THE ROLE OF THROMBIN EXOSITES I AND II IN THE ACTIVATION OF HUMAN COAGULATION FACTOR V
	-	DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
	-	DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA
Séguin C.	-	PROCOAGULANT EFFECT OF DEXAMETHASONE IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS: A POTENTIAL MECHANISM OF GLUCOCORTICOID-INDUCED OSTEONECROSIS
Sei C.	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS
Seibt F.	-	INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
Seidel H.	-	HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Seidlerova J.	-	RISK FACTORS OF INCOMPLETE RECANALISATION AFTER DEEP VEIN THROMBOSIS
Seiffert D.A.	-	INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
Seifried E.	-	FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
	-	IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
Seino Y.	-	TRANSFUSION OF FRESH FROZEN PLASMA AND PLATELETS TO ACHIEVE HEMOSTASIS DURING CARDIOVASCULAR SURGERY INCREASES THE RISK OF POSTOPERATIVE INFECTION
Seita I.	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
	-	FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Seitz R.	-	DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY
Seizer P.	-	PLATELETS, INFLAMMATION AND ATHEROSCLEROSIS
Sekaran M.	-	IS TODAY'S THROMBOPHILIA PROFILE ADEQUATE IN IDENTIFYING A POSSIBLE CAUSE FOR RECURRENT FETAL LOSS IN WOMEN?
Sekhar M.	-	MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
	-	MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
Sekhon A.	-	NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Seki T.	-	A ROLE OF SURFACE-BOUND PLASMINOGEN IN THE LIVER REGENERATION IN RAT
Seki Y.	-	CHARACTERISTIC FEATURES OF SOLUBLE FIBRIN (SF) AND SOLUBLE FIBRIN MONOMER COMPLEX (FMC) AS MEASURED BY IMMUNOASSAYS WITH IATRO SF AND AUTO LIAFM, RESPECTIVELY
Seki T.	-	A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY
Selby R.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
	-	CARDIOVASCULAR RISK FACTORS AND VENOUS THROMBOEMBOLISM: A META-ANALYSIS
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Seldon M.	-	PREANALYTICAL VARIABLES IN THE FLOW CYTOMETRIC ANALYSIS OF MICROPARTICLES
Seligsohn U.	-	A NATURAL MUTATION AND SPECIFIC ARTIFICIAL DELETIONS IN THE BETA3 CYTOPLASMIC TAIL PREVENT ANTIBODY-MEDIATED ACTIVATION OF INTEGRIN ALPHAIIB-BETA3
	-	IS BETA3-ARG261 RESPONSIBLE FOR THE EXCLUSIVE BINDING OF ALPHAIIB TO BETA3?
	-	ALPHA V SUPPRESSION BY SIRNA AUGMENTS OR INHIBITS VEGF AND VEGFR-2 EXPRESSION DEPENDING ON THE ORIGIN OF ENDOTHELIAL CELLS
	-	TWO APPARENT MISSENSE MUTATIONS IN EXONS OF THE FACTOR XI GENE CAUSE SPLICING DEFECTS DISPLAYING A NOVEL MECHANISM FOR MUTATIONS IN CLOTTING FACTORS
	-	SPECIFIC CYSTEINE RESIDUES IN BETA3 ARE ESSENTIAL FOR DISULFIDE BOND EXCHANGE- DEPENDENT OR -INDEPENDENT PATHWAYS OF ALPHAIIBBETA3 ACTIVATION
	-	SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS
	-	FACTOR XI (FXI) IS PRESENT IN ANTI-D PREPARATIONS AND CAN INDUCE AN INHIBITOR TO FXI IN PATIENTS WITH SEVERE FXI DEFICIENCY
	-	A DECREASED INCIDENCE RATE OF ISCHEMIC STROKE IN PATIENTS WITH SEVERE FACTOR XI DEFICIENCY SUGGESTS THAT THE DEFICIENCY CONFERS PROTECTION
	-	FACTOR XI PHENOTYPE-GENOTYPE CORRELATIONS
	-	THREE RESIDUES (L284, I290, Y329) IN THE APPLE 4 DOMAIN OF FACTOR XI (FXI) ARE ESSENTIAL FOR COVALENT DIMERIZATION OF FXI SUBUNITS
	-	THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
Seligson U.	-	The contribution of phospholipids (PL) to thrombin generation (TG) induced by factor eight inhibitor bypassing activity (FEIBA) and recombinant factor VIIa (rFVIIa)
Selistre de Araújo H.S.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Seljeflot I.	-	BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION
	-	ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT
Semenova E.V.	-	D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS
Semeraro F.	-	LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
Semeraro N.	-	LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
	-	IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A
	-	PLASMA FIBRINOLYTIC POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH APC RESISTANCE
Semeraro F.	-	MODERATE HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH REDUCED PLASMA FIBRINOLYTIC CAPACITY AND INCREASED TAFI LEVELS
Semeraro N.	-	MODERATE HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH REDUCED PLASMA FIBRINOLYTIC CAPACITY AND INCREASED TAFI LEVELS
Semple J.W.	-	PLATELETS AND INNATE IMMUNITY
Sen H.	-	RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
Senekowitsch C.	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Senis Y.A.	-	CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS
	-	CD148 IS A POSITIVE REGULATOR OF PLCGAMMA2 ACTIVATION BY GPVI
	-	PLATELET ITIM PROTEINS INHIBIT BASAL SIGNALLING BY YXXL-CONTAINING PLATELET ACTIVATION RECEPTORS
	-	IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
Senis Y.	-	NOVEL PLATELET MEMBRANE RECEPTORS AND SIGNALLING PROTEINS
Sennström M.	-	DALTEPARIN SHORTENS HUMAN LABOR
Senra G.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Seo J.	-	ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
	-	EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
Seralena A.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Serban M.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Serbic O.M.	-	RISK FACTORS FOR THROMBOSIS IN CHILDREN
Serebryakova T.N.	-	SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
	-	EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
Seri M.	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Serino M.L.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Serpa M.G.	-	DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS
	-	ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT
Serra M.	-	SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
Serrano K.	-	APPLICATION OF PROTEOMICS TO THE IDENTIFICATION OF PROTEINS ASSOCIATED WITH THE PLATELET STORAGE LESION AND THEIR TRANSLATION
Serrano M.	-	INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION
Serrano R.	-	EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
	-	THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
Serratosa J.	-	INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION
Sersa I.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Serve E.	-	A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES
Sestini I.	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
Seton-Jones C.	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
Setoodegan F.	-	INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Settasatian C.	-	COMPARATIVE STUDY OF THE EFFECTS OF NATURAL HONEY, SESAME OIL, AND SOY MILK CONSUMPTION ON BLOOD LEVEL OF LIPID PEROXIDATION AND TOTAL PHENOLIC COMPOUNDS
Settasatian N.	-	COMPARATIVE STUDY OF THE EFFECTS OF NATURAL HONEY, SESAME OIL, AND SOY MILK CONSUMPTION ON BLOOD LEVEL OF LIPID PEROXIDATION AND TOTAL PHENOLIC COMPOUNDS
Settergren M.	-	NO EFFECT OF LIPID LOWERING BY SIMVASTATIN OR SIMVASTATIN AND EZETIMIBE ON PLATELET FUNCTION IN PATIENTS WITH TYPE 2 DIABETES OR IMPAIRED GLUCOSE TOLERANCE AND CORONARY ARTERY DISEASE
Setty Y.B.N.	-	HEME INDUCES TISSUE FACTOR EXPRESSION IN HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS: RELATIONSHIP TO CLINICAL HEMOLYTIC STATES
Setyaningsih I.	-	ANTIPHOSPHOLIPID ANTIBODIES IN ADULT -THALASSEMIA
	-	POTENTIAL FACTORS WHICH MAY CAUSE A HIGH LEVEL OF ACA IGG AND IGM
	-	CORRELATION BETWEEN A HIGHER LEVEL OF ACA WITH THE HEMOSTASIS ABNORMALITIES AMONG ADULT -THALASSEMIA
Severin S.	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
Séverin S.	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Severinsen M.T.	-	EPIDEMIOLOGICAL STUDY OF VENOUS THROMBOEMBOLISM IN A BIG DANISH COHORT
Severova T.V.	-	FIRST EXPERIENCE WITH IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA A PATIENTS WITH INHIBITOR TO FACTOR VIII IN RUSSIA
Severs J.	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Seveso M.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Sevestre M.A.	-	IS THROMBO-EMBOLIC DISEASE AN HETEROGENEOUS DISEASE ?
Sevilla J.	-	ACUTE CORONARY SYNDROME AND MEAN PLATELET VOLUME
	-	CAN BLOOD HIPERVISCOSITY BE A PREDICTOR OF ACUTE CORONARY SYNDROME?
Seymour A.L.	-	DIFFERENTIAL EXPRESSION OF TF IN CARDIAC HYPERTROPHY AND ITS INVOLVEMENT IN THE PROGRESSION OF THE DISEASE
Sferruzza A.	-	IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS
Sgouros J.	-	CHEMOANTICOAGULATION VERSUS CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): RESULTS OF THE INTERIM ANALYSIS OF THE FRAGEM TRIAL
Shackell A.	-	REMOVAL OF HUMAN PARVOVIRUS B19 FROM FACTOR IX BY VIRUS FILTRATION
Shah M.D.	-	MEASURING MICROPARTICLES: PITFALLS AND MODIFICATIONS
Shahbazi S.	-	CHARACTERIZATION OF THE INTERACTION BETWEEN VON WILLEBRAND FACTOR AND OSTEOPROTEGERIN
Shahbazi M.	-	DETERMINATION OF PROTEIN C LEVEL IN NEONATES WITH SEPSIS LIKE ILLNESS
Shahin V.	-	THE USE OF ATOMIC FORCE MICROSCOPY TO STUDY COLLAGEN-PLATELET INTERACTIONS
Shahriaran S.	-	THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS
Shahshaahani T.	-	EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
Shahshahani T.	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
	-	THROMBOSIS IN BETA THALASSEMIA MAJOR
Shaji R.	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Shakeri-Nejad K.	-	PHARMACOKINETICS AND PHARMACODYNAMICS OF DABIGATRAN ETEXILATE IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
Shamseddeen W.	-	ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Shamsi T.S.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
	-	USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
Shamsian S.	-	CHILDHOOD GERM CELL TUMOR PRECEDING BY CHRONIC LONGSTANDING DIC
Shang D.	-	OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
Shanker J.	-	PATHOGEN BURDEN AND CORONARY ARTERY DISEASE
	-	FVII ACTIVITY AND R353Q POLYMORPHISM IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE
	-	CONSIDERATION OF MODIFIED CUT-OFFS FOR ANTHROPOMETRIC VARIABLES IN DEFINING METABOLIC SYNDROME AMONG ASIAN INDIANS WITH CORONARY ARTERY DISEASE (CAD)
	-	APOA1 PROMOTER POLYMORPHISMS AND THEIR ASSOCIATION WITH LIPOPROTEINS IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE (CAD)
	-	CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
	-	ASSOCIATION OF CYTOMEGALOVIRUS (CMV) AND PROATHEROGENIC BIOMARKERS IN CORONARY ARTERY DISEASE (CAD)
	-	CORRELATION OF METABOLIC SYNDROME WITH ATHEROGENIC PHENOTYPES IN INDIAN POPULATION
Shanley C.	-	EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
	-	LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
Shanmugaonkar M.	-	CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Shantilisa E.	-	RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS
Shao C.	-	CRYSTAL STRUCTURE OF THE C2 DOMAIN OF LACTADHERIN
Shapiro A.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Shapiro N.	-	EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
Shaposhnikov S.A.	-	A TECHNIQUE FOR PREVENTION OF THROMBOSIS AFTER ABDOMINAL SURGERY
	-	EVALUATION OF CLOT DENSITY AS AN INTEGRAL MARKER OF COAGULOPATHY
Shariat-Madar Z.	-	SCUPA OR FXII STIMULATE ERK1/2 OR AKT THROUGH UPAR AND BETA 1 INTEGRINS
Sharifi Z.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Sharifian R.A.	-	EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
Sharkova T.S.	-	EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
	-	SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
Shavit J.A.	-	REGULATION OF PLASMA VON WILLEBRAND FACTOR (VWF) BY MODIFIER GENES
Shaw A.W.	-	BLOOD COAGULATION REACTIONS ON NANOSCALE MEMBRANE SURFACES
Shaw G.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Shawwa A.	-	USE OF A CLINICAL ALGORITHM IN THE DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA
Shearer M.J.	-	URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS
Shearer M.	-	UNEXPECTED FINDING OF RAISED UNDERCARBOXYLATED FII (PIVKA-II) IN FVII DEFICIENCY
	-	POISONING WITH SUPERWARFARIN
Shearer M.J.	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
Sheehan J.P.	-	THE HEPARIN-BINDING EXOSITE IS CRITICAL TO ALLOSTERIC ACTIVATION OF FACTOR IXA IN THE INTRINSIC TENASE COMPLEX:
Sheehan N.R.	-	TRANSIENT REVERSAL OF THE ANTI-PLATELET EFFECT OF ASPIRIN AFTER ADMINISTRATION OF UNFRACTIONATED HEPARIN IN HEALTHY SUBJECTS
Sheen L.	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Sheereen A.	-	THE 4G/5G INSERTION/DELETION POLYMORPHISM OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
Sheffield W.P.	-	EXTRA- AND INTRA-REACTIVE CENTRE LOOP ALTERATIONS TO ALPHA-1-PROTEINASE INHIBITOR ENHANCE ITS SPECIFIC INHIBITION OF THROMBIN
Sheiner T.	-	PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
Shek P.N.	-	THROMBELASTOGRAPHY STUDY OF HEMOSTATIC AGENTS
Shen Y.	-	RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI
	-	CONTROL SHEDDING OF GPIB-IX-V AND GPVI BY ADAM FAMILY METALLOPROTEINASES
Shen M.C.	-	NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Shen F.	-	STUDY OF ANTI-ANGIOGENESIS EFFECT INDUCED BY MER IN VITRO AND ITS MECHANISM
	-	TWO NOVEL MONOCLONAL ANTIBODIES TO VWFA3 INHIBIT VWF-COLLAGEN AND VWFPLATELET GPIB INTERACTIONS
Shen M.C.	-	SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
Shen M.	-	REFERENCE RANGE OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY CHINESE
Shen M.C.	-	SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Shenker A.	-	EXPOSURE-CLINICAL OUTCOME MODELING AND SIMULATION TO FACILITATE DOSE SELECTION OF APIXABAN IN SUBJECTS UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT SURGERY
	-	APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
	-	APIXABAN, AN ORAL DIRECT, FACTOR XA INHIBITOR: SINGLE-DOSE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Shenkman B.	-	RESPONSIVENESS TO CLOPIDOGREL AND ASPIRIN AMONG PATIENTS WITH ACUTE CORONARY SYNDROME AS ASSESSED BY THE IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	PLATELET GPIIBIIIA-FIBRINOGEN BINDING ACTIVITY IS INCREASED BY ALLICIN (A THIOL-REACTIVE REAGENT)
	-	ROLE OF COLLAGEN IN PLATELET-DEPENDED CD4+ T CELL ADHESION
	-	CLOPIDOGREL UNRESPONSIVENESS OVERCOME BY RELOADING: ASSESSEMENT BY PLATELET AGGREGOMETRY AND IMPACT-R [CONE AND PLATE(LET) ANALYZER]
	-	TESTING AGONIST-INDUCED PLATELET AGGREGATION BY THE IMPACT-R
Sheorajpanday R.	-	GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
Sheppard C.	-	HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
Sheppard B.L.	-	DIFFERENTIAL EFFECTS OF TRANSDERMAL AND ORAL ESTRADIOL/NORETHISTERONE ACETATE HORMONE THERAPIES ON COAGULATION AND FIBRINOLYTIC MARKERS
	-	SEX STEROIDS USED IN HORMONE TREATMENT ALTER COAGULATION GENE EXPRESSION IN CULTURED HUVEC
Sherman D.G.	-	ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Shetty K.	-	PROTEIN S DEFICIENCY IN HIV INFECTED PEDIATRIC PATIENTS ON ANTIRETROVIRAL THERAPY
Shetty S.	-	CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	DEEP VENOUS THROMBOSIS IN THE ANTENATAL PERIOD IN A LARGE COHORT OF PREGNANCIES FROM WESTERN INDIA
	-	THROMBOPHILIA AS A CAUSE OF UNEXPLAINED FETAL LOSS IN INDIAN PATIENTS AN IN DEPTH STUDY
Sheydina A.M.	-	PREVALENCE OF FACTOR V LEIDEN, PROTHROMBIN G20210A, AND 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE MUTATIONS IN A HEALTHY RUSSIAN POPULATION
Shi J.	-	RELATIONSHIP OF PROCOAGULANT ACTIVITY TO PHOSPHATIDYLSERINE EXPOSURE ON IMMORTALIZED ACUTE PROMYELOCYTIC LEUKEMIA CELLS
Shi G.	-	SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
	-	KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
	-	THE REGULATION OF THROMBOMODULIN DISTRIBUTION IN ENDOTHELIAL CELLS
	-	RECOMBINANT HUMAN THROMBOMODULIN PROMOTES SMOOTH MUSCLE CELL MIGRATION
	-	DEXTROMETHORPHAN REDUCES ATHEROSCLEROSIS AND NEOINTIMA FORMATION IN MICE
Shi Y.	-	CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Shi Q.	-	TRANSPLANT BONE MARROW THAT IS GENETICALLY MODIFIED TO EXPRESS FVIII ONLY IN PLATELETS CAN RESTORE HEMOSTASIS TO HEMOPHILIA A MICE ON A STRONG INHIBITOR BACKGROUND
Shiach C.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
Shibamiya A.	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
	-	1,25(OH)2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB
Shibano T.	-	THE PHARMACOLOGICAL PROFILE OF DZ-697B, A NOVEL ANTI-PLATELET AGENT
	-	COMPARISON OF ANTITHROMBOTIC PROPERTIES OF A DIRECT FXA INHIBITOR, DU-176B, WITH AN ANTITHROMBIN DEPENDENT FXA INHIBITOR, FONDAPARINUX, IN A CAPILLARY PERFUSION CHAMBER THROMBOSIS MODEL
	-	EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
	-	ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE, RECOMBINANT FACTOR VIII AND FACTOR IX REVERSE PROLONGED CLOTTING TIME INDUCED BY DU-176B, A DIRECT FACTOR XA INHIBITOR, IN HUMAN PLASMA
	-	EFFECT OF A FACTOR XA INHIBITOR DU-176B ON INTRACEREBRAL HEMORRHAGE IN RATS: A WIDER SAFETY MARGIN COMPARED WITH A THROMBIN INHIBITOR
	-	GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
Shibata T.	-	USEFULNESS OF A D-DIMER KIT NEWLY DEVELOPED FOR STANDARDIZATION
Shibata M.	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
Shibeko A.M.	-	THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR
	-	BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING
Shibutani T.	-	THE PHARMACOLOGICAL PROFILE OF DZ-697B, A NOVEL ANTI-PLATELET AGENT
Shibuya K.	-	POSSIBLE INVOLVEMENT OF CD226 IN CELLULAR INTERACTION OF MEGAKARYOCYTES WITH ENDOTHELIAL CELLS DURING MEGAKARYOPOIESIS AND PLATELET PRODUCTION
Shibuya A.	-	POSSIBLE INVOLVEMENT OF CD226 IN CELLULAR INTERACTION OF MEGAKARYOCYTES WITH ENDOTHELIAL CELLS DURING MEGAKARYOPOIESIS AND PLATELET PRODUCTION
Shick S.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Shields D.C.	-	A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION
Shigaki T.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Shigenaga T.	-	BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
Shihong I.	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Shiller E.	-	HAEMORRHAGES SYMPTOMS IN GIRL WITH FACTOR XII SEVERE DEFICIENCY
Shiller E.E.	-	MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
Shiltag N.	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Shiltagh N.	-	LONG TERM FOLLOW-UP OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN THE MANAGEMENT OF MENORRHAGIA IN WOMEN WITH INHERITED BLEEDING DISORDERS
Shima M.	-	GLOBAL ASSAY USING CLOT WAVEFORM AND THROMBIN GENERATION ASSAY
Shimada K.	-	RISK FACTOR PROFILE AND PATTERN OF USE OF MEDICATIONS IN JAPANESE PATIENTS AT A HIGH RISK OF CARDIOVASCULAR DIEASE: RESULTS FROM THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY AND CEREBROVASCULAR DISEASE (J-TRACE)
Shimanova Y.V.	-	VARIATIONS OF PLATELET GLYCOPROTEIN IIB-IIIA QUANTITY AFFECTS PLATELET AGGREGATION AND SENSITIVITY TO GLYCOPROTEIN IIB-IIIA ANTAGONISTS
Shimazaki S.	-	THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Shimizu Y.	-	EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
Shimonishi S.	-	A ROLE OF SURFACE-BOUND PLASMINOGEN IN THE LIVER REGENERATION IN RAT
Shin Y.	-	A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Shin L.Y.Y.	-	EFFECTS OF CHEMOTHERAPY AGENTS ON ENDOTHELIAL AND MONOCYTE HEMOSTASIS
Shin J.	-	BIOCHEMICAL ANALYSIS OF RECOMBINANT FIBRINOGEN AALPHAGLN328PRO; PREVIOUSLY REPORTED AS FIBRINOGEN VARIANT SEOUL II WITH IMPAIRED FIBRIN ALPHA-CHAIN CROSS-LINKING
Shin H.	-	POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
Shingu T.	-	ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
Shinozaki M.	-	IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Shinozawa K.	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
	-	CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
	-	FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
	-	ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION
Shiozaki N.	-	FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
Shirafuji N.	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
Shiraga M.	-	SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Shirakawa R.	-	GTP-INDUCED DENSE GRANULE SECRETION IN PLATELETS IS MEDIATED BY RAL-EXOCYST PATHWAY
Shiranita A.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Shirasaki Y.	-	EFFECT OF A FACTOR XA INHIBITOR DU-176B ON INTRACEREBRAL HEMORRHAGE IN RATS: A WIDER SAFETY MARGIN COMPARED WITH A THROMBIN INHIBITOR
Shirokova T.E.	-	MODULATION OF PLATELET REACTIVITY BY ERYTHROCYTES IN CORONARY ARTERY DISEASE PATIENTS TAKING ASPIRIN
Shiu Y.	-	ENHANCED HEPARIN BINDING AFFINITIES INCREASE THE EFFICIENCIES AT WHICH THE BETA-ANTITHROMBIN III ISOFORM AND A RECOMBINANT ATIII VARIANT LOAD ONTO PENTASACCHARIDE-BEARING SURFACES UNDER FLOW
Shlansky-Goldberg R.	-	A PHASE I TRIAL OF LOCALLY-DELIVERED HUMAN PLASMIN TO EVALUATE SAFETY AND THROMBOLYTIC EFFICACY IN PATIENTS WITH HEMODIALYSIS GRAFT OCCLUSION (HGO)
Shlomai G.	-	PRO- AND ANTI-ANGIOGENIC CYTOKINES ARE CONDITIONALLY AND SELECTIVELY RELEASED FROM ALPHA-GRANULES UPON PLATELET STIMULATION
Shmeleva V.M.	-	APOE GENE POLYMORPHISM CAN MODIFY THE RISK OF VENOUS THROMBOEMBOLISM
	-	THE ROLE OF DNA POLYMORPHISMS IN GENES CODING THE HOMOCYSTEINE AND FOLATE METABOLIZING ENZYMES IN ISCHAEMIC HEART DISEASE
	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON THE ACTIVITY OF CATALASE
	-	HOMOCYSTEINE LEVELS AND PREVALENCE OF C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN CHILDREN WITH MIGRAINE
	-	PREVALENCE OF HYPERHOMOCYSTEINEMIA IN WOMEN WITH PREMENSTRUAL SYNDROME AND EFFECT OF ORAL AND VAGINAL DELIVERY OF ETHINYL ESTRADIOL AND DEZOGESTREL ON HOMOCYSTEINE LEVELS
	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH PREGNANCY LOSS AND GESTATIONAL OUTCOME IN WOMEN WITH DIAGNOSED THROMBOPHILIA FOLLOWING ANTITHROMBOTIC THERAPY
	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON FIBRINOLYTIC AND ANTICOAGULANT SYSTEMS IN PATIENTS WITH ACUTE CORONARY SYNDROME
	-	HYPERHOMOCYSTEINEMIA AND FACTOR V LEIDEN ACT SYNERGISTICALLY INCREASING RISK OF VEIN THROMBOSIS IN NORTH-WESTERN RUSSIA
	-	HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
Shmirev I.I.	-	THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR
Shoji S.	-	TRANSFUSION OF FRESH FROZEN PLASMA AND PLATELETS TO ACHIEVE HEMOSTASIS DURING CARDIOVASCULAR SURGERY INCREASES THE RISK OF POSTOPERATIVE INFECTION
Sholkamy S.	-	EFFICACY AND SAFETY OF A NOVEL HANSENULA POLYMORPHA -DERIVED RECOMBINANT RB-VARIANT HIRUDIN FOR THROMBOPROPHYLAXIS IN ORTHOPAEDIC PATIENTS
Shopnick R.	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
Shore A.	-	COMPLEMENT C3 IS A PLASMA CLOT COMPONENT AND INFLUENCES CLOT LYSIS
	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Short P.E.	-	A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
Shouda Y.	-	EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Shouno S.	-	PLATELET VOLUME IN CORD BLOOD
Shouzu A.	-	EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Shoya Y.	-	ACTIVATION OF ANTITHROMBIN BY SEQUENTIAL DELETION OF TWO AND THREE SUCCESSIVE RESIUES IN THE C-TERMIANL REGION OF THE REACTIVE CENTER LOOP
Shpilberg O.	-	ANTI-CD 20 MONOCLONAL ANTIBODY (RITUXIMAB) AS AN OPTIONAL TREATMENT FOR INTRACTABLE ACQUIRED GLANZMANN THROMBASTHENIA
Shrier I.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Shrivastava S.	-	MODULATION OF DENDRITIC CELL FUNCTION BY TISSUE FACTOR AND COAGUALTION PROTEASES
Shroff M.	-	OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS
Shubeilat T.S.	-	INHERITED BLEEDING DISORDERS- A 14 YEAR RETROSPECTIVE STUDY
Shworak N.W.	-	ANTICOAGULANT HEPARAN SULFATES MODULATE TISSUE REMODELING AT OVULATION
Sibi K.	-	APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
Sibille M.	-	IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
	-	NEUTRALIZATION BY AVIDIN OF ANTICOAGULANT ACTIVITY OF BIOTINYLATED IDRAPARINUX, THE FIRST AND UNIQUE REVERSIBLE LONG-ACTING ANTICOAGULANT
Siboni S.M.	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
	-	ARTERIOVENOUS FISTULA (AVF) IS A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	PORT IS NOT A SAFE AND SUITABLE VENOUS ACCESS FOR IMMUNE TOLERANCE TREATMENT (ITT) IN HEMOPHILIC CHILDREN
Siciliano S.	-	1800NOCLOTS WHAT HAVE WE LEARNED FROM THIS FREE CONSULTATIVE SERVICE
Sideris G.	-	BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
Sidhu P.S.	-	ASSOCIATION BETWEEN ASYMPTOMATIC DEEP-VEIN THROMBOSIS DETECTED BY SCREENING VENOGRAPHY AND SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING ELECTIVE HIP OR KNEE SURGERY A SYSTEMATIC REVIEW
Sidyakova E.V.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Sié P.	-	TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE
Sie P.	-	ESTIMATING THE INFLUENCE OF MEASUREMENT VARIABILITY ON DIAGNOSTIC ERRORS: A BAYESIAN MODEL APPLIED TO QUANTITATIVE D DIMER ASSAYS FOR THE EXCLUSION OF VENOUS THROMBOSIS
	-	AUTOMATED QUANTIFICATION OF VON WILLEBRAND FACTOR ACTIVITY WITH HEMOSIL ON THE CA 7000 COAGULOMETER: A VALIDATION STUDY
	-	COMPONENTS OF VARIABILITY OF D DIMER MEASUREMENT CLOSE TO THE CUT-OFF VALUE
	-	MICROPARTICLES FROM APOPTOTIC MONOCYTES (M-MPS) INDUCE TRANSIENT PLATELET RECRUITMENT AND TISSUE FACTOR (TF) EXPRESSION BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS VIA A REDOX-SENSITIVE MECHANISM
Sieber M.W.	-	EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
Sieder C.	-	CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
Siegbahn A.	-	ANTIAPOPTOTIC SIGNALING BY TF/FVIIA IS INHIBITED BY SIMVASTATIN
	-	GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
	-	TISSUE FACTOR/FACTOR VIIA COMPLEX REGULATES PDGF-BB-INDUCED CHEMOTAXIS THROUGH SRC FAMILY KINASE SIGNALING
	-	ADP INDUCED TF PRODUCTION BY FORMATION OF PLATELET-MONOCYTE AGGREGATES IS NOT EFFECTED BY DIRECT THROMBIN INHIBITORS
	-	GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Siegemund A.	-	MONITORING AND THERAPY OF SEVERE ANTITHROMBIN DEFICIENCY IN PREGNANT WOMEN
Siegemund T.	-	MONITORING AND THERAPY OF SEVERE ANTITHROMBIN DEFICIENCY IN PREGNANT WOMEN
	-	THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
Siegemund A.	-	THROMBIN GENERATION IN PATIENTS WITH HAEMOPHILIA AND VWD COMPARISON FLUORIMETRIC METHOD AND ROTEM
Siegemund T.	-	THROMBIN GENERATION IN PATIENTS WITH HAEMOPHILIA AND VWD COMPARISON FLUORIMETRIC METHOD AND ROTEM
	-	INHIBITOR AGAINST F V MONTORING WITH THROMBIN GENERATION ASSAYS
Siegemund R.	-	INHIBITOR AGAINST F V MONTORING WITH THROMBIN GENERATION ASSAYS
Siegemund T.	-	MONITORING NOVOSEVEN THERAPY WITH DIFFERENT METHODS
Siegemund R.	-	MONITORING NOVOSEVEN THERAPY WITH DIFFERENT METHODS
Siegemund A.	-	THROMBIN GENERATION AND THE TYPE OF ANTITHROMBIN DEFICIENCY
	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	THROMBIN GENERATION IN PATIENTS WITH THROMBOPHILIA OR THROMBOSIS AND PREGNANCY
Siegemund T.	-	THROMBIN GENERATION IN PATIENTS WITH THROMBOPHILIA OR THROMBOSIS AND PREGNANCY
Siegemund A.	-	PLATELET FUNCTION IN IMMUNE THROMBOCYTOPENIA (M. WERLHOF)
Siegert G.	-	INFLUENCE OF DESMOPRESSIN ON HEMOSTASIS IN CHILDREN WITH BLEEDING DISORDERS
	-	THE ANTICOAGULANT PROTEINS S AND ANTITHROMBIN DISPLAY REMARKABLE SEX-DEPENDENT CHANGES DURING AGING
Sieghart W.	-	EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
	-	EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
Siegmund B.	-	ON DEMAND TREATMENT AND CONTINUOUS PROPHYLAXIS OF ADULT HAEMOPHILIA A PATIENTS: A COMPARATIVE RETROSPECTIVE DATA ASCERTAINMENT
Siekmann J.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
Sierko E.	-	EXPRESSION OF TISSUE FACTOR (TF), FACTOR X, PROTHROMBIN FRAGMENT 1+2 (F 1+2) AND FIBRIN IN BREAST CANCER: COMPARISON BETWEEN PRIMARY TUMOR AND METASTATIC LESIONS IN REGIONAL LYMPH NODES
Siess W.	-	THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
	-	EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES
	-	THE EFFECT OF ADP RECEPTOR ANTAGONISTS AND ASPIRIN ON WHOLE BLOOD PLATELET AGGREGATION MEASURED BY MULTIPLE ELECTRODE AGGREGOMETRY
Sieuwerts A.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Sigaud M.	-	CAN THROMBIN GENERATION BE HELPFUL TO EVALUATE THE BLEEDING PHENOTYPE IN MILD HEMOPHILIA A WITH FACTOR VIII ASSAY DISCREPANCY?
	-	SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
Siguret V.	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
	-	OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
	-	IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
Siigur J.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Siigur E.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Silasi-Mansat R.	-	GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
Silence K.	-	A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS
Silina N.N.	-	HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON FIBRINOLYTIC AND ANTICOAGULANT SYSTEMS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Silingardi M.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Siljander P.R.M.	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
	-	PLATELET RECEPTOR RECOGNITION AND CROSSTALK IN COLLAGEN-INDUCED ACTIVATION OF PLATELETS
	-	GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
Silva F.C.L.	-	RISK FACTORS ASSOCIATED TO THE DEVELOPMENT OF PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Silva L.J.	-	HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
Silva F.C.L.	-	PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND OTHER PARAMETERS INTERRELATED IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	ASSOCIATION BETWEEN PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND SMOKING IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	HEMOSTATIC PROFILE IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD): ASSOCIATION TO ANKLE-BRACHIAL INDEX (ABI)
Silveira A.	-	ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA)
	-	ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
Silver L.E.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
Silver L.	-	LACK OF PREDICTIVE VALUE OF HIGH SHEAR PLATELET FUNCTION IN A POPULATION BASED COHORT STUDY OF ACUTE VASCULAR EVENTS
Silverio S.A.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Silverman T.	-	INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA A: IS THE RISK ASSOCIATED WITH PRODUCT TYPE?
Silvestrelli G.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Silvestri C.	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
Sim D.S.	-	ANTAGONISM OF INTRINSIC PATHWAY INHIBITS TISSUE FACTOR (TF)-INITIATED COAGULATION IN A PLATELET-DEPENDENT WHOLE BLOOD FLOW ASSAY
	-	A NOVEL FAMILY OF ALKYLATED QUINOLINES INHIBITS G PROTEIN-COUPLED RECEPTORS WITH PALMITOYLATED CYTOPLASMIC TAILS
	-	MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI)
Sim D.	-	PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL
Sim S.	-	A ROLE FOR ADIPONENCTIN IN HUMAN PLATELET FUNCTION?
Simanek R.	-	SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
	-	A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
	-	PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE)
	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
Simanis R.	-	NATURAL CLEARANCE OF HEPATITIS C VIRUS INFECTION AND HUMAN LEUKOCYTE ANTIGEN CLASS II ALLELES IN CHILDREN WITH HAEMOPHILIA
Simazu C.	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
Simchen M.J.	-	PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA
	-	HIGH PROPORTION OF MATERNAL THROMBOPHILIA AMONG PREVIOUSLY UNEXPLAINED STILLBIRTH CASES
Simeoni U.	-	PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES
Simes J.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Simic S.M.	-	COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM?
Simioni M.	-	ANTITHROMBIN DEFICIENCY IN THE GENERAL POPULATION IS RARELY DUE TO AT GENE MUTATIONS, WHICH ARE MAINLY REPRESENTED BY ALA384SER MUTATION
Simioni P.	-	INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
	-	ISOLATION AND CHARACTERIZATION OF AN ANTI-FACTOR VIII ANTIBODY FROM A PATIENT WITH ACQUIRED HEMOPHILIA
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	PLATELET POLYPHOSPHATE MODULATES PLATELET COAGULATION PROTEIN RESPONSES
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
	-	GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
	-	FACTOR V LEIDEN IS ASSOCIATED WITH MORE DISTAL LOCATION OF DEEP VEIN THROMBOSIS OF THE LEG
	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Simmet T.	-	THROMBIN INDUCES ACTIVATION OF MATURED DENDRITIC CELLS VIA RHO/ERK PATHWAYS
	-	PLASMIN INDUCES PROINFLAMMATORY STIMULATION OF HUMAN MACROPHAGES VIA THE ANNEXIN A2 HETEROTETRAMER
	-	THROMBIN STIMULATION AMPLIFIES MONOCYTIC/ENDOTHELIAL CELL CROSS-TALK AND SUBSEQUENT MCP-1 RELEASE THROUGH FRACTALKINE BINDING
Simó M.	-	CLINICAL MANAGEMENT USING LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN PREGNANT WOMEN WITH THROMBOPHILIA, THROMBOEMBOLIC DISEASE (DVT) OR THROMBOPHILIA-RELATED MATERNOPLACENTAL SYNDROME: EXPERIENCE IN ONE CENTER
Simón A.A.	-	DEFINITIVE PACEMAKER'S IN ANTICOAGULATED PATIENTS
Simon D.I.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Simón M.	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
Simon T.	-	EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
Simoncini S.	-	COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES
Simoneau G.	-	HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
	-	D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
Simonneau G.	-	ENOXAPARIN 40 MG VERSUS NADROPARIN 0.3 ML IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) IN COLORECTAL CANCER SURGERY ACCORDING TO AGE AND CREATININE CLEARANCE (CRCL)
	-	TREATMENT OF VTE DURING PREGANCY WITH A ONCE-DAILY REGIMEN OF LMWH
Simons R.M.	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
Simonson A.B.	-	VASCULAR PROTEOMIC MAPPING IN VIVO
Simpson A.M.C.	-	THE USE OF ATOMIC FORCE MICROSCOPY TO STUDY COLLAGEN-PLATELET INTERACTIONS
Simpson-Haidaris P.J.	-	FIBRINOGEN SYNTHESIZED BY CANCER CELLS AUGMENTS THE PROLIFERATIVE EFFECT OF FGF-2
Sinauridze E.I.	-	HEMODILUTION CAUSES HYPERCOAGULABILITY
Singla A.	-	SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
	-	MYONECROSIS IS PREDICTED BY HIGH REACTIVITY TO MULTIPLE PLATELET AGONISTS: A TRANSLATIONAL STUDY OF PATIENTS UNDERGOING STENTING TREATED WITH BIVALIRUDIN AND HIGH DOSE CLOPIDOGREL
	-	PATIENTS WITH METABOLIC SYNDROME DEMONSTRATE HIGH PLATELET REACTIVITY AND INCREASED PROCOAGULANT MARKERS
Sinha D.	-	FACTOR XIA RESIDUES TYR143, GLU98, AND LYS192 ARE IMPORTANT FOR SUBSTRATE FACTOR IX (FIX) AND S-2366 CATALYSIS
Sinha U.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
	-	ANTAGONISM OF INTRINSIC PATHWAY INHIBITS TISSUE FACTOR (TF)-INITIATED COAGULATION IN A PLATELET-DEPENDENT WHOLE BLOOD FLOW ASSAY
Sinha D.	-	MECHANISMS OF FACTOR XIA INHIBITION BY TWO KUNITZ TYPE INHIBITORS, PROTEASE NEXIN 2 KPI DOMAIN AND BASIC PANCREATIC TRYPSIN INHIBITOR (BPTI)
Sinigaglia F.	-	DEHYDROEPIANDROSTERONE INHIBITS PLATELET AGGREGATION
	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
	-	EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
Sinkov S.V.	-	A TECHNIQUE FOR PREVENTION OF THROMBOSIS AFTER ABDOMINAL SURGERY
	-	EVALUATION OF CLOT DENSITY AS AN INTEGRAL MARKER OF COAGULOPATHY
	-	THE PROTOCOL FOR DIAGNOSTICS AND INTENSIVE CARE OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME
Sinzinger H.	-	PLATELET RESPONSE DOES NOT CHANGE DURING LONG-TERM-TREATMENT (8YEARS) WITH 50 OR 100 MG ACETYLSALICYLIC ACID (ASA) FOR SECONDARY PREVENTION
Sipos T.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Sirachainan N.	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
	-	NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
Siragusa S.	-	ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
Siret L.	-	ANALYZE OF THE CO-PURIFIED PROTEINS WITH A HIGHLY PURIFIED PLASMA-DERIVED FACTOR VIII: FVIII-SD-35-15
Sirijaichingkul S.	-	COMPARATIVE STUDY OF THE EFFECTS OF NATURAL HONEY, SESAME OIL, AND SOY MILK CONSUMPTION ON BLOOD LEVEL OF LIPID PEROXIDATION AND TOTAL PHENOLIC COMPOUNDS
Sirireung S.	-	NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
Sirol M.	-	BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
Sironi L.	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Sirotkina N.N.	-	LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA
Sirotkina O.V.	-	PREVALENCE OF FACTOR V LEIDEN, PROTHROMBIN G20210A, AND 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE MUTATIONS IN A HEALTHY RUSSIAN POPULATION
	-	VARIATIONS OF PLATELET GLYCOPROTEIN IIB-IIIA QUANTITY AFFECTS PLATELET AGGREGATION AND SENSITIVITY TO GLYCOPROTEIN IIB-IIIA ANTAGONISTS
Sirotkina O.	-	THE VITAMIN K EPOXIDE REDUCTASE GENE POLYMORPHISMS AND PHARMACOGENETICS OF WARFARIN
Sirotkina N.N.	-	IDIOPATHIC THROMBOCYTOPENIC PURPURA AND OPPORTUNISTIC INFECTIONS IN CHILDREN
	-	MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
Sischka W.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Sitia R.	-	MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
Sitrin R.G.	-	SCUPA OR FXII STIMULATE ERK1/2 OR AKT THROUGH UPAR AND BETA 1 INTEGRINS
Sitruk-Ware R.	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
Sittinger K.	-	PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
	-	IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
Siudak Z.	-	ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
Sivachenko Y.B.	-	SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE
Sivasubramaniam M.	-	FUNCTIONAL CHARACTERISATION OF HAPLOTYPIC VARIATION IN THE GP6 GENE PROMOTER
Sjörin E.	-	FEMALE HEMOPHILIA A - TWO UNUSUAL CASES DUE TO SKEWED X-INACTIVATION
	-	STUDIES OF mRNA IN PATIENTS WITH UNDETECTABLE MUTATIONS IN GENOMIC DNA
Skeate R.C.	-	THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
Skenderi K.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
Skeppholm M.	-	COMPARISON OF THREE DIFFERENT TAFI ASSAYS IN PATIENTS WITH ACUTE CORONARY SYNDROME
	-	INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
	-	MEASUREMENTS OF FIBRINOGEN AND CRP CONCENTRATIONS IN EDTA AND CITRATE PLASMA
Skerrette N.I.	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
Skibo G.G.	-	NEUROPROTECTIVE EFFECTS OF QUERCETIN IN A GERBIL MODEL OF CEREBRAL ISCHEMIA
	-	MODULATION OF NITRIC OXIDE PRODUCTION BY CULTURED ENDOTHELIAL CELLS
Skjønsberg O.H.	-	FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
Skoda R.	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Skolnick B.E.	-	LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
Skrakova M.	-	TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
Skretting G.	-	EXPRESSION OF THE TFPI V264M MUTANT IN VASCULAR CELL CULTURES INVOLVES STABILITY OF MRNA
Skvortsova E.	-	THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
Slaba I.	-	STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
Slack S.M.	-	GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
	-	TYROSINE KINASE SYK PLAYS A PIVOTAL ROLE IN PLATELET SIGNALING INITIATED BY PATHOPHYSIOLOGICAL SHEAR STRESS
Slaoui M.	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
	-	SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS
Slatter D.A.	-	PLATELET RECEPTOR RECOGNITION AND CROSSTALK IN COLLAGEN-INDUCED ACTIVATION OF PLATELETS
Slavik L.	-	AGGREGATION TEST FOR DETECTION CLOPIDOGREL RESISTANCE
	-	THROMBIN GENERATION TEST AN EXPERIENCE OF ONE CENTRE IN THROMBOPHILIA PATIENTS
	-	TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN ACTIVATOR INHIBITOR-1 AND VON WILLEBRAND FACTOR IN THE ACUTE AND CONVALESCENT PHASE OF ISCHEMIC STROKE
	-	ROLE OF THROMBOPHILIC RISK FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Sligar S.G.	-	BLOOD COAGULATION REACTIONS ON NANOSCALE MEMBRANE SURFACES
Slingerland R.J.	-	NOVEL MOLECULAR DEFECT IN THE PLATELET ADP RECEPTOR P2Y12 OF A PATIENT WITH HAEMORRHAGIC DIATHESIS
Slivankova E.V.	-	PREVALENCE OF HYPERHOMOCYSTEINEMIA IN WOMEN WITH PREMENSTRUAL SYNDROME AND EFFECT OF ORAL AND VAGINAL DELIVERY OF ETHINYL ESTRADIOL AND DEZOGESTREL ON HOMOCYSTEINE LEVELS
Slofstra S.H.	-	INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	GENE EXPRESSION PROFILING IDENTIFIES C/EBP-DELTA AS A CANDIDATE REGULATOR OF ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
Slungaard A.	-	ENDOGENOUS PLATELET FACTOR 4 INCREASES ACTIVATED PROTEIN C GENERATION AND IMPROVES SURVIVAL AFTER LIPOPOLYSACCHARIDE CHALLENGE
Smadja D.	-	BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
Smadja D.M.	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
	-	THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS
Small D.S.	-	EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
Smart R.C.	-	SENSITIVITY AND SAFETY OF PULMONARY EMBOLI IMAGING WITH RADIOLABELED ANTI-D-DIMER MONOCLONAL ANTIBODY FRAGMENTS
Smart R.	-	EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
Smedsrød B.	-	ROLE OF LIVER SINUSOIDAL ENDOTHELIAL CELLS IN ELIMINATION OF HEPARIN
Smejkal P.	-	ACQUIRED FACTOR VIII INHIBITOR: REPORT FROM THE REGIONAL HAEMOPHILIA CENTRE
	-	THE DIFFERENT SENSITIVITY OF TWO APTT REAGENTS FOR DIAGNOSIS OF LUPUS ANTICOANGULANT
	-	EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR
Smerling C.	-	LIGAND-RECEPTOR AFFINITY AND RHO-FAMILIY GTPASES IN INTEGRIN ALPHA2BETA1-MEDIATED PROCESSES
Smethurst P.A.	-	GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
Smid M.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS
	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Smirnov M.	-	THROMBOPATH KIT CORRELATES BETTER WITH FREE PROTEIN S TO PROTHROMBIN RATIO AND FUNCTIONAL PS THAN WITH FREE PS
	-	ILPCA, A RECOMBINANT PC ACTIVATOR SUCCESSFULLY USED TO FORMULATE AN AUTOMATED PC CHROMOGENIC ASSAY IN LIQUID FORMAT
	-	THROMBOPATH KIT HAS INCREASED SENSITIVITY TO PROTHROMBOTIC LUPUS ANTICOAGULANTS
	-	DIRECT PROTECTIVE EFFECT OF ACTIVATED PROTEIN C ON MAST CELLS DEGRANULATION
Smirnova O.A.	-	THE ROLE OF DNA POLYMORPHISMS IN GENES CODING THE HOMOCYSTEINE AND FOLATE METABOLIZING ENZYMES IN ISCHAEMIC HEART DISEASE
	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON FIBRINOLYTIC AND ANTICOAGULANT SYSTEMS IN PATIENTS WITH ACUTE CORONARY SYNDROME
	-	HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
Smith N.L.	-	ASSOCIATION OF BLOOD PRESSURE AND FACTOR VIII IN LEIDEN THROMBOPHILIA STUDY (LETS) AND CARDIOVASCULAR HEALTH STUDY (CHS)
Smith T.M.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Smith S.A.	-	FACTOR VIIA-ANTITHROMBIN COMPLEXES IN HUMAN PLASMA
Smith K.C.	-	A COVALENT REACTIVE ANTIGEN ANALOG TO FACTOR VIII REDUCES ANTIBODY PRODUCTION IN MEMORY B CELLS AFTER RE-STIMULATION WITH FVIII
Smith P.	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION
Smith K.A.	-	MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN
Smith K.M.	-	IDENTIFICATION OF A BINDING SITE FOR FACTOR XA ON THE LIGHT CHAIN OF FACTOR VA
Smith S.A.	-	PLATELET POLYPHOSPHATE MODULATES PLATELET COAGULATION PROTEIN RESPONSES
Smith G.	-	FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
	-	LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
Smith L.	-	CONTINUOUS INFUSION OF A HIGH PURITY FACTOR IX (HPFIX) CONCENTRATE IN SURGERY
Smith G.E.L.	-	BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
Smith V.C.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Smith J.M.	-	ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
Smith G.	-	CLINICAL DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Smith K.A.	-	THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION
Smith N.L.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
Smith K.M.	-	ISOLATION AND CHARACTERIZATION OF AN ANTI-FACTOR VIII ANTIBODY FROM A PATIENT WITH ACQUIRED HEMOPHILIA
Smith G.	-	THROMBOPHILIA IN PAEDIATRIC CYSTIC FIBROSIS PATIENTS
Smithline H.A.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Smiti M.	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Smolarczyk K.	-	REGULATORY EFFECT OF ALPHA1-ACID GLYCOPROTEIN ON PAI-1 REDISTRIBUTION ON ENDOTHELIAL CELLS SURFACE
	-	KU80 AS A NOVEL RECEPTOR FOR THYMOSIN BETA4 THAT MEDIATES ITS INTRACELLULAR ACTIVITY DIFFERENT FROM G ACTIN SEQUESTERING
Smyth S.S.	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
Smythe M.A.	-	AN EVALUATION OF AN ARGATROBAN DOSE TITRATION NOMOGRAM
	-	ARGATROBAN DOSE REQUIREMENTS IN INTENSIVE CARE UNIT PATIENTS
Snir A.	-	EFFECT OF FIBRIN MATRICES ON INCREASED PROLIFERATION AND SPREADING OF EARLY TERM TROPHOBLASTS AND PLACENTAL VILLI. MODULATION OF COAGULATION AND ANGIOGENESIS FUNCTIONS
Snoep J.D.	-	CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
	-	LABORATORY-DEFINED ASPIRIN RESISTANCE IS ASSOCIATED WITH A HIGHER RISK OF RECURRENT CARDIOVASCULAR EVENTS: A META-ANALYSIS
	-	HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES
Sobas F.	-	THE IMPORTANCE OF TYPE OF QUALITY CONTROL WHEN CHANGING REAGENT BATCHES
Sobieraj-Teague M.	-	LABORATORY DIAGNOSIS OF THE DISCREPANT PHENOTYPE OF MILD HAEMOPHILIA A USING A MODIFIED CHROMOGENIC FACTOR VIII ASSAY
Sobocka M.B.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Socher I.	-	SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES
	-	HEPARIN INDEPENDENT ACTIVATION OF PLATELETS BY HIT ANTIBODIES. A COMMON OCCURRENCE
	-	HETEROGENEITY OF HPA-3 ALLOANTIBODIES: CONSEQUENCES FOR THE DIAGNOSIS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Sochnevs A.	-	NATURAL CLEARANCE OF HEPATITIS C VIRUS INFECTION AND HUMAN LEUKOCYTE ANTIGEN CLASS II ALLELES IN CHILDREN WITH HAEMOPHILIA
Sodi A.	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
Soebardi S.	-	METABOLIC SYNDROME IN ISCHEMIC STROKE PATIENTS' CHILD
Soejima K.	-	ADAMTS13 STRUCTURE AND FUNCTION
	-	DOES DIFFERENT D-DIMER LEVEL REDUCE THE USE OF VENOUS DUPLEX SCANNING TO RULE OUT DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM?
	-	FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13
	-	ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
	-	PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
	-	THE UTILITY OF QUANTITATIVE CALF MUSCLE NEARINFRARED SPECTROSCOPY IN THE FOLLOWUP OF ACUTE DEEP VEIN THROMBOSIS
Soffredini R.	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
Sofi F.	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
	-	GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
Soheily Z.	-	THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Sohn Y.	-	ANTITHROMBOTIC EFFECT OF RECOMBINANT DISINTEGRIN IN A MOUSE THROMBOSIS MODEL
Sohne M.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Sokolikova B.	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Sokolova N.A.	-	CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
Sol J.J.	-	VENOUS THROMBOSIS AND THE POST THROMBOTIC SYNDROME AFTER FEMORAL CATHETERIZATION
Solá E.	-	INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE
Solchenberger B.	-	CLINICAL EFFICACY OF ANTI-VENOM TREATMENT IN PAPUAN NEW GUINEA SNAKE-BITE PATIENTS
Soldera C.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Soldi A.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
Solé G.	-	PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
Soller M.J.	-	FEMALE HEMOPHILIA A - TWO UNUSUAL CASES DUE TO SKEWED X-INACTIVATION
Sollevi A.	-	INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
Solomon C.	-	AN EVALUATION OF SINGLE PORTION REAGENT VIALS FOR ROTEM ANALYSIS
Solpov A.V.	-	LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS
	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
	-	CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
	-	ROLE OF COLLAGEN IN PLATELET-DEPENDED CD4+ T CELL ADHESION
Soltész P.	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Soltesz P.	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Solymoss S.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
Somaini M.G.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Somani R.	-	COMPLEMENT C3 IS A PLASMA CLOT COMPONENT AND INFLUENCES CLOT LYSIS
Somma C.	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Sommeijer D.W.	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
Sompalli S.	-	BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
Son J.	-	EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Sonevytsky A.	-	DEFIBROTIDE MEDIATED INHIBITION OF HEPARINASE I. POTENTIAL CLINICAL IMPLICATIONS
Song J.	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
Sood R.	-	MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
Sood S.L.	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Soomro N.	-	USE OF RECOMBINANT ACTIVETED FACTOR VII FOR THE CONTROL OF POST PARTUM HEMORRHAGE: A CASE SERIES
Soop A.	-	INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
Soosairajah J.	-	A NOVEL SINGLE-CHAIN (SCFV) ANTIBODY PHAGE-DISPLAY STRATEGY FOR THE DEVELOPMENT OF POTENTIAL ANTI-ATHEROSCLEROTIC DRUGS
Sørensen B.	-	EVALUATION OF COAGULATION KINETICS USING THROMBELASTOGRAPHY
Sørensen B.B.	-	IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
Sorensen H.T.	-	VENOUS THROMBOEMBOLISM AND SUBSEQUENT HOSPITALIZATION DUE TO ACUTE CARDIOVASCULAR EVENTS. A 20 YEARS FOLLOW-UP STUDY
Sørensen B.B.	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
Sørensen B.	-	MONITORING HAEMOSTATIC RESPONSE USING DYNAMIC FIBRIN GENERATION METHODS
	-	ROTEM THROMBELASTOMETRY ANALYTICAL CONTROL, VARIATION, AND VALIDATION USING A FROZEN PLATELET RICH PLASMA CONTROL AND ACTIVATION WITH MINUTE AMOUNTS OF TISSUE FACTOR
	-	PLATELET INFUSION IMPROVED THE HAEMOSTATIC EFFECT OF RECOMBINANT FACTOR VIIA IN A PATIENT WITH INHIBITOR HAEMOPHILIA UNDERGOING ELECTIVE KNEE REPLACEMENT: SIGNIFICANCE OF THE RFVIIA GLA-DOMAIN BINDING TO PLATELETS
Sorensen B.B.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
	-	RECOMBINANT ACTIVATED HUMAN FACTOR VII (FVIIA) BINDS TO THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS (HUVEC)
Sorge R.	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Soria J.	-	UP-REGULATION OF ACTIVATED PROTEIN-C RECEPTOR ON HUMAN ENDOTHELIAL CELLS BY ALDOSTERONE
Soria J.M.	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Soria C.	-	PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG
Soria J.M.	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
Soria J.	-	MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
	-	PLASMA ANGIOGENIC ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
	-	BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE
	-	HUMAN MALIGNANT CELLS EXPRESS FUNCTIONALLY ACTIVE ENDOTHELIAL PROTEIN C RECEPTOR
Soria C.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
Soria J.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Sors H.	-	RISK FACTORS AND CLINICAL SIGNIFICANCE OF RESIDUAL PERFUSION DEFECTS AFTER SYMPTOMATIC PULMONARY EMBOLISM
Sortino G.	-	PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
	-	THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
Soscov G.	-	HAEMORRHAGES SYMPTOMS IN GIRL WITH FACTOR XII SEVERE DEFICIENCY
Sosin M.	-	CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH PLASMA MARKERS OF PRO-ATHEROGENIC PROCESSES IN RHEUMATOID ARTHRITIS
Soskov G.I.	-	IDIOPATHIC THROMBOCYTOPENIC PURPURA AND OPPORTUNISTIC INFECTIONS IN CHILDREN
	-	LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA
Sossa Melo C.L.	-	SURGICAL REMOVAL OF A PSEUDOTUMOR IN A PATIENT WITH HEMOPHILIA A AND INHIBITORS: A COLOMBIAN CASE STUDY
Soto M.	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
Soto C.	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
Soto-Ribeiro M.	-	FACTOR VII ACTIVATING PROTEASE (FSAP) REGULATES CELL ADHESION AND MOTILITY BY MULTIPLE MECHANISMS
Soucie J.M.	-	BASELINE QUALTIY OF LIFE (QOL) IN HEMOPHILIA PATIENTS RECEIVING CARE AT U.S. CENTERS
	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
	-	JOINT RANGE OF MOTION (ROM) MEASUREMENTS IN PATIENTS WITH VON WILLEBRAND DISEASE COMPARED WITH NORMAL SUBJECTS
Souibri M.	-	A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS
Soulié B.	-	SECONDARY PROPHYLAXIS WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A SEVERE HAEMOPHILIA A PATIENT WITH ANTI-FACTOR VIII INHIBITORS
Souquieres M.	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
Souri M.	-	HUMAN PROTEIN Z GENE EXPRESSION IS REGULATED BY HNF-4ALPHA AND SP1, INDEPENDENT OF WARFARIN AND VITAMIN K
	-	GAMMA-GLUTAMYL CARBOXYLASE-DEPENDENT SECRETION OF PROTEIN Z
	-	STRUCTURE-FUNCTION RELATIONSHIP OF FXIIIB: ITS ROLES IN OLIGOMER ASSEMBLY, STABILITY AND ACTIVITY OF COAGULATION FACTOR XIII
Sousa M.O.	-	TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS
	-	SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
	-	APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE
	-	LIPOPROTEIN(A) IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD), ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS
	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
	-	SECRETORY PHOSPHOLIPASE A2 AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN CORONARY ARTERY DISEASE
	-	LACK OF ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISM AND ATHEROMATOSIS EXTENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
	-	ASSOCIATION OF OXIDIZED LDL AND LP(A) LIPOPROTEIN WITH EXTENT OF CORONARY ARTERY DISEASE BY ANGIOGRAPHY
	-	CORONARY ARTERY DISEASE (CAD): LACK OF ASSOCIATION BETWEEN APOB/APOA-I RATIO AND ATHEROMATOSIS EXTENT
	-	RISK FACTORS ASSOCIATED TO THE DEVELOPMENT OF PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Soutari N.	-	THE EXPRESSION OF PLATELET RECEPTORS AND MARKERS OF PLATELET ACTIVATION IN PATIENTS WITH HEMOPHILIA A AND VON WILLEBRANDS DISEASE
Souto J.	-	MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
Souto J.C.	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
Souto J.	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Souza F.	-	DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Souza M.O.	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
Souza G.C.	-	807C/T POLYMORPHISM IN THE PLATELET GLYCOPROTEIN IA GENE IN PATIENTS WITH RETINAL VEIN OCCLUSION
Sovershaev M.	-	DETERMINATION OF TISSUE FACTOR ORIGIN USING SIRNA KNOCKDOWN APPROACH IN HUMAN PERIPHERAL BLOOD WHITE CELLS
Spaan J.	-	COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
Spaargaren-van Riel C.C.	-	THE EFFECT OF THE INTRONIC PROTHROMBIN 19911G ALLELE ON 3' END MRNA PROCESSING IN RELATION TO THE 20210GA POLYMORPHISM
Spahn D.R.	-	TREATMENT OF LIFE THREATENING BLEEDING
Spalton J.C.	-	PLATELET ITIM PROTEINS INHIBIT BASAL SIGNALLING BY YXXL-CONTAINING PLATELET ACTIVATION RECEPTORS
Spannagl M.	-	PLATELET RESPONSIVENESS TOWARDS ANTIPLATELET MEDICATIONS BEFORE AND AFTER CORONARY ANGIOGRAPHY AND PERCUTENOUS CORONARY INTERVENTIONS AS DETERMINED BY WHOLE BLOOD AGGREGOMETRY
	-	INFLUENCE OF FV LEIDEN ON THE KINETICS OF THROMBIN FORMATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST (TDT)
	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	EFFECTIVENESS OF CHRONIC ANTIPLATELET TREATMENT BY ASPIRIN OR CLOPIDOGREL AS DETERMINED BY MULTIPLE ELECTRODE AGGREGOMETRY
	-	ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
	-	MONITORING OF ANTIPLATELET THERAPY BEFORE AND AFTER SURGICAL PROCEDURES IN PATIENTS WITH CORONARY STENTS
	-	EFFECT OF VARIATIONS OF SINGLE FACTOR ACTIVITY ON THROMBIN GENERATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST
	-	THERAPEUTIC DRUG MONITORING OF HEPARINS AND DIRECT THROMBIN INHIBITORS: THE GERMAN EXTERNAL QUALITY ASSESSMENT SCHEME
Sparks E.A.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Spavour M.	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
Spears M.D.	-	EFFICACY OF WHOLE BLOOD PLATELET AGGREGATION IN THE EVALUATION OF BLEEDING OR THROMBOTIC TENDENCIES
Specchia M.	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Specker E.	-	DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY
Spector T.D.	-	HERITABILITY OF MEASURES OF CLOT TURBIDITY AND CLOT LYSIS IN THE LEEDS FAMILY STUDY
	-	PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
Spectre G.	-	PLATELETS AND SUBENDOTHELIAL MATRIX PROTEINS DIFFERENTIALLY SUPPORT ADHESION OF LYMPHOCYTE SUBPOPULATIONS UNDER ARTERIAL SHEAR STRESS
Spedini P.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Speer C.P.	-	PLATELET PROINFLAMMATORY AND HEMOSTATIC FUNCTIONS IN PATIENTS WITH CYSTIC FIBROSIS
	-	PLATELET-LEUKOCYTE INTERACTION: A CLEAR AGE DEPENDENCY
Speich H.E.	-	GPIIB-IIIA ANTAGONISTS HAVE A SIGNIFICANT EFFECT ON THROMBUS STABILITY BY DISPLACING BOUND FIBRINOGEN
	-	TYROSINE KINASE SYK PLAYS A PIVOTAL ROLE IN PLATELET SIGNALING INITIATED BY PATHOPHYSIOLOGICAL SHEAR STRESS
Speidl W.S.	-	IN HUMAN MACROPHAGES THE COMPLEMENT COMPONENT C5A INDUCES THE EXPRESSION OF ONCOSTATIN M VIA AP-1 ACTIVATION
	-	THROMBIN UPREGULATES EXPRESSION OF ONCOSTATIN M (OSM) IN HUMAN MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES
	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
Spek C.A.	-	FACTOR (F)XA STIMULATES FIBROPROLIFERATIVE RESPONSES IN FIBROBLASTS VIA PROTEASE ACTIVATED RECEPTOR (PAR)-2 ACTIVATION: IMPLICATIONS FOR TISSUE REMODELING
Spek A.	-	ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL
Spek C.A.	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
	-	GENE EXPRESSION PROFILING IDENTIFIES C/EBP-DELTA AS A CANDIDATE REGULATOR OF ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS
	-	INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	COAGULATION FACTOR XA INHIBITS CANCER CELL MIGRATION VIA LIMK1-MEDIATED COFILIN INACTIVATION
Spek A.C.	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
Spek C.A.	-	`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN
Spek C.	-	GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
Spena S.	-	MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES
	-	A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE
Spencer H.T.	-	IDENTIFICATION OF A CLINICALLY RELEVANT GENE THERAPY STRATEGY TO TREAT HEMOPHILIA A USING A HIGH-EXPRESSION FACTOR VIII VECTOR AND GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS
	-	GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS ENCODING PORCINE FACTOR VIII INDUCE PROCOAGULANT ACTIVITY IN HEMOPHILIA A MICE WITH PRE-EXISTING FACTOR VIII IMMUNITY
Sperandio O.	-	DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
Spiel A.O.	-	EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
	-	ETHNIC DIFFERENCES IN A HUMAN MODEL OF TISSUE FACTOR- TRIGGERED COAGULATION
Spiel A.	-	STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
Spiel A.O.	-	EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Spiezia L.	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
	-	VENOUS THROMBOSIS DURING ORAL CONTRACEPTION IN NORMAL OR THROMBOPHILIC WOMEN WHO HAD REMAINED ASYMPTOMATIC DURING PAST PREGNANCIES
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
	-	ISOLATION AND CHARACTERIZATION OF AN ANTI-FACTOR VIII ANTIBODY FROM A PATIENT WITH ACQUIRED HEMOPHILIA
	-	INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
Spila A.	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
Spinelli A.	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
Spira J.	-	EFFICACY AND SAFETY OF FVIII WITH PEGYLATED LIPOSOMES IN HAEMOPHILIA A
	-	COMPARISON OF PEGYLATED LIPOSOMAL FVIII INFUSION RATES IN HEMOPHILIA A
Spirito R.	-	BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM
Spohn G.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Spotti E.	-	EVALUATION OF A NEW D-DIMER METHOD
Spotts G.	-	ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS)
	-	ASSESSMENT OF THROMBOTIC ADVERSE EVENTS (TAES) WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES (APCCS): 17 YEAR EXPERIENCE
	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION
	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
Spranger T.	-	PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS?
Spreafico M.	-	MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
	-	MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
Spring C.M.	-	ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Springolo F.	-	SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY
Spronk H.M.H.	-	THROMBIN GENERATION AND COAGULATION MARKERS IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION
	-	THROMBOXANE B2 IN PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION: THE INFLUENCE OF TREATMENT WITH ACETYLSALICYLIC ACID
	-	ACTIVE SITE INHIBITED FACTOR VIIA REDUCES MYOCARDIAL INFARCT SIZE AFTER ISCHEMIA/REPERFUSION INJURY IN MICE VIA TISSUE FACTOR/NFKAPPAB-MEDIATED MECHANISMS
	-	ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS
Spronk H.	-	THE NECESSITY OF CONTINUOUS INDIVIDUAL CALIBRATION IN CONTINUOUS FLUOROGENIC MEASUREMENT OF THE THROMBIN GENERATION CURVE
Spronk H.M.H.	-	LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	CIRCULATING MATRIX GLA PROTEIN: A POTENTIAL MARKER FOR VASCULAR COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
	-	LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT)
	-	COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION
	-	LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS
	-	CHARACTERIZATION OF THE ROLE OF PLATELET ADHESION MOLECULES IN A MURINE MODEL OF PHOTOSENSITIZER-INDUCED STROKE
	-	ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS
	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
	-	THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS
	-	THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS
Spyropoulos A.C.	-	THROMBOEMBOLISM AND BLEEDING OUTCOMES OF LOW-MOLECULAR-WEIGHT HEPARIN BRIDGING THERAPY DURING PERI-PROCEDURE WARFARIN INTERRUPTION: PATIENT-LEVEL POOLED DATA OF FOUR COHORT STUDIES
	-	UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY
Squizzato A.	-	SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
	-	THYROID DISEASES AND THE COAGULATION SYSTEM: A SYSTEMATIC REVIEW
Sreckovic V.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Sridhara M.	-	LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
Srivastava A.	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
	-	MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
	-	HEREDITARY DYSFUNCTIONAL FACTOR X IS THAT PASSOVOY FACTOR?
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Stadler M.	-	PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
	-	VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
	-	PRODUCT FEATURES OF THE NOVEL GENERATION VWF/FVIII CONCENTRATE IN A COMPARISON WITH FIRST GENERATION PRODUCTS
Staehle H.	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Staelens S.	-	NOVEL INTERACTING PROTEINS WITH PLATELET 21 CYTOPLASMIC TAILS: RHOGDI AND SLAP-2
	-	THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS
	-	THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA
	-	THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS
	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Stafford A.R.	-	ZINC PROMOTES FORMATION OF TERNARY THROMBIN-FIBRIN-HEPARIN COMPLEXES BY ENHANCING HEPARIN-FIBRIN AFFINITY
	-	ANTICOAGULANT PROPERTIES OF HD1, A (PRO)THROMBIN-DIRECTED DNA APTAMER
	-	HISTIDINE-RICH GLYCOPROTEIN (HRG) MODULATES THE FUNCTION OF FXII IN HEMOSTASIS
	-	BIVALENT BINDING OF THROMBIN TO GAMMA'-FIBRIN ENHANCES PROTECTION FROM INHIBITION BY ANTITHROMBIN-HEPARIN
Stagg S.	-	REMOVAL OF HUMAN PARVOVIRUS B19 FROM FACTOR IX BY VIRUS FILTRATION
Stähle H.	-	COADMINISTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DICLOFENAC HAS LITTLE IMPACT ON THE PHARMACOKINETICS OF EITHER DRUG
	-	COADMINSTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND ATORVASTATIN HAS LITTLE IMPACT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EITHER DRUG
	-	PHARMACOKINETICS AND PHARMACODYNAMICS OF DABIGATRAN ETEXILATE IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
Stahle M.C.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
Stähle H.	-	NO INTERACTION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DIGOXIN
Stahmann N.	-	THROMBIN STIMULATES AMP-ACTIVATED PROTEIN KINASE IN ENDOTHELIAL CELLS VIA A CAMKK-BETA-DEPENDENT PATHWAY
Staines H.	-	ACTIVATED FACTOR XII TYPE A INDEPENDENTLY PREDICTS 12 MONTH MORTALITY IN CHEST PAIN PATIENTS
Stakiw J.	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
Stalc M.	-	ENDOTHELIAL FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND HISTORY OF VENOUS THROMBOSIS
Stalker T.J.	-	JUNCTIONAL ADHESION MOLECULE A (JAM-A) NEGATIVELY REGULATES AGONIST-INDUCED PLATELET ACTIVATION
	-	THE TIGHT JUNCTION PROTEIN ESAM IS RECRUITED TO PLATELET-PLATELET CONTACTS AND FORMS SIGNALING COMPLEXES THAT AFFECT THROMBUS GROWTH AND STABILITY
	-	IDENTIFICATION OF NOVEL PLATELET MEMBRANE PROTEINS USING MULTI-DIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY
Stalker T.	-	LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
Stamer K.	-	THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
Stana L.	-	HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Stancheva A.G.	-	ROTATION THROMBELASTOGRAPHY APPROACH DURING LIVER TRANSPLANTATION
Standeven K.F.	-	RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY
	-	COMPLEMENT C3 IS A PLASMA CLOT COMPONENT AND INFLUENCES CLOT LYSIS
Stangier J.	-	PHARMACOKINETICS AND PHARMACODYNAMICS OF DABIGATRAN ETEXILATE IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
	-	COADMINSTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND ATORVASTATIN HAS LITTLE IMPACT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EITHER DRUG
	-	COADMINISTRATION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DICLOFENAC HAS LITTLE IMPACT ON THE PHARMACOKINETICS OF EITHER DRUG
	-	NO INTERACTION OF THE ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE AND DIGOXIN
Stankovic S.G.	-	A VERY RARE CONGENITAL BLEEDIND DISORDER-BERNARD SOULIER SYNDROME, FOUND IN A FAMILY IN MACEDONIA
	-	INTENSIVE PLASMA EXCHANGE WAKES UP PATIENT WITH TTP IN COMA
Starke R.D.	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
	-	DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS)
	-	FXI/ADAMTS13 COMPLEX IN PLASMA
Staroverov I.	-	D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS
Stasko J.	-	STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
	-	ACQUIRED HAEMOPHILIA A WITH INHIBITOR - CASE REPORT
Stasyshyn O.	-	CLINICAL EXPERIENCE WITH A HIGH PURITY FACTOR IX CONCENTRATE IN YOUNG CHILDREN
	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Stauch M.	-	PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Staudt A.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) AND DILATED CARDIOMYOPATHY (DCM) - PARALLELS IN THE PATHOGENESIS OF TWO SEVERE IMMUNE MEDIATED CARDIOVASCULARE DISORDERS
Stavarova Y.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Stavenuiter F.	-	THE MARBURG-1 MUTATION REDUCES THE AUTOCATALYTIC ACTIVITY OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP)
Stebbings Y.	-	IMMUNE-TOLERANCE IN HAEMOPHILIA A USING PLASMA-DERIVED FACTOR VIII CONCENTRATE FANHDI
	-	AUDIT OF SCREENING FOR VON WILLEBRANDS DISEASE AND PLATELET FUNCTION ABNORMALITIES USING THE PFA-100
Steele B.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
Steenstrup T.D.	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
Stefanin C.	-	EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS
Stefano P.	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
Stefanska E.	-	A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
	-	WHAT DOES HIGH PREVALANCE OF FACTOR V LEIDEN MUTATION IN POLISH SEVERE HAEMOPHILIACS MEAN?
	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
	-	"IMPACT R" - A NEW SCREENING TOOL FOR VON WILLEBRAND DISEASE?
	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/4G GENOTYPE MAY INCREASE THE RISK OF THROMBOSIS IN SUBSET OF PATIENTS WITH PROTHROMBIN G20210A GENE MUTATION
Steffan A.	-	ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX
	-	A NOVEL FLOW CYTOMETRIC METHOD FOR THE DETECTION OF RETICULATED PLATELETS BY AN ANTI-BROMODEOXYURIDINE MONOCLONAL ANTIBODY
	-	CEREBROVASCULAR THROMBOSIS DURING ESTROPROGESTINIC THERAPY IN A YOUNG WOMAN
	-	HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST
Steg P.G.	-	MECHANISMS ASSOCIATED WITH FAILURE OF THROMBOLYTIC THERAPY TO RECANALIZE THE INFARCT ARTERY IN ACUTE MYOCARDIAL INFARCTION
Stegnar M.	-	MATRIX METALLOPROTEINASE-3, TISSUE INHIBITOR OF METALLOPROTEINASES-1 AND WARFARIN TREATMENT
	-	VENOUS THROMBOEMBOLISM ASSOCIATED POLYMORPHISMS IN SLOVENE POPULATION
	-	OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT
	-	IS BIOLOGICAL VARIATION OF PLATELET FUNCTION TESTS TOO HIGH FOR RELIABLE DETECTION OF ASPIRIN RESISTANCE?
Stehouwer C.D.A.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
Steigerwald U.	-	CROSS-TALK OF VWF/GPIB- AND NO/CGMP-INDUCED SIGNALING IN HUMAN PLATELETS
Steil L.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Stein S.F.	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
	-	ASSESSMENT OF PLATELET FUNCTION IN NORMAL ADULTS: RISTOCETIN-INDUCED PLATELET AGGREGATION (RIPA)
Steinberg J.M.	-	Prospective Evaluation of a Quantitative D-dimer for Pulmonary Embolism: is Structured Pretest Probability Assessment Always Needed?
Steinberg D.M.	-	A DECREASED INCIDENCE RATE OF ISCHEMIC STROKE IN PATIENTS WITH SEVERE FACTOR XI DEFICIENCY SUGGESTS THAT THE DEFICIENCY CONFERS PROTECTION
Steinbergs J.	-	DNR ANALYSIS RESULTS IN THROMBOSES PATIENTS: THE FIRST DATA IN LATVIA
Steinbrenner D.	-	PLATELET RESPONSE DOES NOT CHANGE DURING LONG-TERM-TREATMENT (8YEARS) WITH 50 OR 100 MG ACETYLSALICYLIC ACID (ASA) FOR SECONDARY PREVENTION
Steiner T.	-	LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
Steinhubl S.R.	-	MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY
Steinoe A.	-	CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
	-	RECOMBINANT ACTIVATED HUMAN FACTOR VII (FVIIA) BINDS TO THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS (HUVEC)
Steinsvik B.	-	DIFFERENTIAL EFFECTS OF CONVENTIONAL DOSE HORMONE THERAPY, LOW DOSE HT, TIBOLONE AND RALOXIFENE ON C-REACTIVE PROTEIN AND OTHER INFLAMMATORY MARKERS
Stellos K.	-	ASPIRIN-RESISTANCE IN CHILDREN
Stemmelin G.	-	EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
	-	LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
Stemple D.L.	-	USE OF HAEMOPHILIA A ZEBRAFISH FOR SENSITIVE SCREENING AND CHARACTERISATION OF NOVEL PLATELET CANDIDATE GENES DERIVED FROM POST-GENOME STUDIES FOR PRO-THROMBOTIC FUNCTION
Stendardo A.	-	LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
Sten-Linder M.	-	THE EXPRESSION OF PLATELET RECEPTORS AND MARKERS OF PLATELET ACTIVATION IN PATIENTS WITH HEMOPHILIA A AND VON WILLEBRANDS DISEASE
Stenmo C.B.	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
Stennicke H.R.	-	CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	RECOMBINANT ACTIVATED HUMAN FACTOR VII (FVIIA) BINDS TO THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS (HUVEC)
	-	FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
	-	PROBING THE ORIGINS OF ACTIVITY ENHANCEMENT IN FACTOR VIIA (FVIIA) VARIANTS BY HYDROGEN EXCHANGE MASS SPECTROMETRY (HX-MS)
	-	COAGULATION FACTOR VIIA VARIANTS WITH REDUCED SUSCEPTIBILITY TO INHIBITION BY ANTITHROMBIN III
	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
	-	IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
Stepenski P.	-	ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Stephan J.	-	HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
Stephens J.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
Stephens D.	-	THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
Stephens J.C.	-	REGULATION OF THE PLATELET PROCOAGULANT RESPONSE
Stephens D.	-	ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS)
Stephens J.	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
Stephens G.	-	DIFFERENTIAL EFFECTS OF ANTI-PLATELET DRUGS ON THROMBUS FORMATION AND THROMBUS STABILITY
Stepien E.	-	FOLIC ACID ADMINISTRATION AND PLATELET ACTIVATION AT THE SITE OF MICROVASCULAR INJURY IN SUBJECTS WITH ELEVATED TOTAL HOMOCYSTEINE
	-	REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
	-	CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
	-	C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
	-	ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
	-	NO DECREASE IN THROMBIN FORMATION AT THE SITE OF MICROVASCULAR INJURY IN PATIENTS TREATED WITH CLOPIDOGREL
Stergiou G.	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Stern J.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Stevenson K.	-	LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
Steward M.	-	NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
Stewart D.	-	A NEW ANIMAL MODEL OF CATHETER-SELECTIVE MIDDLE CEREBRAL ARTERY THROMBO-OCCLUSIVE STROKE: DEMONSTRATION OF RAPID REPERFUSION BY LOCAL PLASMIN INFUSION
Sticchi E.	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
Stiegler G.	-	FUNCTIONAL COAGULATION ANALYSIS IN PATIENTS WITH BLOOD COAGULATION DISORDERS OR HYPERCOAGULABILITY: SIGNIFICANCE OF WHOLE BLOOD ROTATION THROMBELASTOGRAPHY IN COMPARISON WITH CONVENTIONAL BLOOD COAGULATION ANALYSIS
Stiekema J.	-	FACTOR (F)XA STIMULATES FIBROPROLIFERATIVE RESPONSES IN FIBROBLASTS VIA PROTEASE ACTIVATED RECEPTOR (PAR)-2 ACTIVATION: IMPLICATIONS FOR TISSUE REMODELING
	-	COAGULATION FACTOR XA INHIBITS CANCER CELL MIGRATION VIA LIMK1-MEDIATED COFILIN INACTIVATION
Stieler J.	-	PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Stirling D.	-	EFFECT OF PRE-ANALYTICAL VARIABLES ON MICROPARTICLE NUMBERS
Stivelband I.B.	-	LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP
Stobart K.	-	SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS OF PROPHYLACTIC CLOTTING FACTOR CONCENTRATE IN HEMOPHILIA
Stockschlaeder M.	-	FONDAPARINUX IS A SAFE AND EFFECTIVE ALTERNATIVE ANTICOAGULANT IN PREGNANT WOMEN WITH INTOLERANCE TO LOW-MOLECULAR- WEIGHT HEPARINS AND HEPARINOIDS
Stoddard M.F.	-	ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Stoellberger C.	-	REVERSE-HYBRIDIZATION-BASED GENETIC TESTING FOR THE PREDICTION OF ANTICOAGULANT DOSE REQUIREMENT
Stoffers H.E.J.H.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS
Stoffman J.	-	NEONATAL RENAL VEIN THROMBOSIS - 15 YEARS OF LITERATURE
Stoilova-McPhie S.	-	A CRYO-ELECTRON MICROSCOPY STUDY OF RECOMBINANT FVIII BINDING TO PS LIPOSOMES
	-	DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA
	-	3D STRUCTURES OF MEMBRANE-BOUND FACTOR VIII
Stojakovic T.	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Stojanovic A.	-	A VERY RARE CONGENITAL BLEEDIND DISORDER-BERNARD SOULIER SYNDROME, FOUND IN A FAMILY IN MACEDONIA
Stokman G.	-	UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
Stoll M.	-	INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
Stoll G.	-	INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
Stoll M.	-	HAPLOTYPES OF THE PROTEIN Z GENE ASSOCIATED WITH SYMPTOMATIC THROMBOEMBOLISM IN CHILDREN
Stoll H.	-	IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
Stoll P.	-	CONFORMATION-SPECIFIC BLOCKADE OF THE INTEGRIN GPIIB/IIIA): IN VITRO AND IN VIVO RESULTS DEMONSTRATING A SELECTIVE PLATELET BLOCKADE WITH LESS ADVERSE EFFECTS
Stolla M.	-	THE CHEMOKINE FRACTALKINE MEDIATES LEUKOCYTE RECRUITMENT TO INFLAMMATORY ENDOTHELIUM AT ARTERIAL SHEAR RATES IN VIVO AND IN VITRO
Stolyarova E.P.	-	FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA
Stolz E.	-	INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Stone G.W.	-	MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY
Stone P.H.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Stone N.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Storelli C.	-	THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1
	-	THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION
	-	HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS
	-	HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
Storey R.F.	-	INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
	-	P2Y12 BLOCKADE BY PRASUGREL ACTIVE METABOLITE YIELDS COMPLETE INHIBITION OF P2Y12-MEDIATED AMPLIFICATION OF PLATELET RESPONSES
Stormer J.	-	MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
	-	FAMILY HISTORY OF MYOCARDIAL INFARCTION (MI) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
Storojevykh T.P.	-	ANTI-APOPTOTIC EFFECTS OF SERINE PROTEINASES OF HEMOSTASIS AT GLUTAMATE-INDUCED NEUROTOXICITY
Storr J.	-	ANTI XA ASSAYS FOR DANAPAROID: ASSESSMENT OF PRE ANALYTICAL AND ANALYTICAL VARIABLES
Storti S.	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Stott S.	-	ANTICOAGULANT MANAGEMENT USING AN INTERNET BASED MONITORING SYSTEM
Stotz G.M.	-	AN ENU MUTAGENESIS SCREEN FOR DOMINANT GENETIC MODIFIERS OF THROMBOSIS IN THE FACTOR 5 LEIDEN MOUSE
Stouffer R.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Strambovskaya N.N.	-	THE CARRIAGE OF FV G1691A, FII G20210A, MTHFR C677T GENES IN PATIENTS WITH ISCHEMIC STROKE IN BURYATS AND RUSSIANS
Strandberg K.	-	CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH
	-	CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH
Stranden E.	-	BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
Strangi R.	-	ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
Strassel C.	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
	-	MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES
	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
Strater R.D.	-	INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
Straub J.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Straume B.	-	FREQUENCY AND TIME OF ONSET OF ACUTE MYOCARDIAL INFARCTION IN SUDDEN UNEXPECTED DEATHS IN A FORENSIC AUTOPSY MATERIAL
Straume B.K.	-	PLATELET DEPOSITION IN RABBIT COMMON CAROTID ARTERIES PROMOTED BY ARTERIAL STENOSIS AND SPASM
Strauss J.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Strauss C.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Strauss J.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Streater G.	-	THE ROLE OF FC-GAMMA RECEPTOR GENE POLYMORPHISMS IN THE CLINICAL OUTCOME OF NEWLY DIAGNOSED ITP IN CHILDREN
Streer N.P.	-	HEPARIN-INDUCED PLATELET AGGREGATION DOES NOT PREDICT THE PRESENCE OF ANTI-HEPARIN ANTIBODIES
Street A.	-	2B OR NOT 2B? DISPARATE DISCRIMINATION OF FUNCTIONAL VWF DISCORDANCE USING DIFFERENT ASSAYS OR METHODOLOGIES FOR VWF LEADS TO SUCCESS OR FAILURE IN THE EARLY IDENTIFICATION OF TYPE 2B VWD
Strehl A.	-	DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION
	-	RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
Streif W.	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
	-	DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
	-	VARIABILITY IN PERFORMING PLATELET AGGREGOMETRY FOR DIAGNOSIS OF INBORN DISORDERS OF PLATELET FUNCTION IN GERMANY, AUSTRIA AND SWITZERLAND
Strelnicova E.V.	-	PLASMAFHERESIS (PA) INFLUENCE ON MORPHOLOGICAL STATUS OF PLATELES (PLT) AT WOMEN WITH SPONTANEOS ABORTIONS - INFLAMMATORY GENESIS
Stricker H.	-	CANOLA OIL, BUT NOT SUNFLOWER OIL, DECREASES CHOLESTEROL AND IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE: A DOUBLE-BLIND, RANDOMIZED INTERVENTIONAL STUDY
Strickland S.	-	FIBRIN DEPOSITION ACCELERATES NEUROVASCULAR DAMAGE AND NEUROINFLAMMATION IN MOUSE MODELS OF ALZHEIMER'S DISEASE
Strickland D.K.	-	IDENTIFICATION OF A NOVEL ENDOTHELIAL CELL RECEPTOR FOR FIBRIN
Strobel U.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
Stroobants A.K.	-	COMPARATIVE STUDY ON APTT REAGENTS
Strukova S.	-	DIRECT PROTECTIVE EFFECT OF ACTIVATED PROTEIN C ON MAST CELLS DEGRANULATION
Strukova S.M.	-	ANTI-APOPTOTIC EFFECTS OF SERINE PROTEINASES OF HEMOSTASIS AT GLUTAMATE-INDUCED NEUROTOXICITY
	-	PAR1 AGONISTS ACCELERATE ULCER HEALING IN RATS
Struve S.	-	MANAGEMENT OF SEVERE PULMONARY EMBOLISM IN A PATIENT WITH HOMOZYGOUS PROTEIN C DEFICIENCY
Stuart M.	-	HEME INDUCES TISSUE FACTOR EXPRESSION IN HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS: RELATIONSHIP TO CLINICAL HEMOLYTIC STATES
Stuckey A.	-	HIGH DOSE FACTOR VIIA CORRECTS THROMBIN GENERATION IN A MODEL OF DILUTIONAL COAGULOPATHY
Sturgeon S.	-	FERRIC CHLORIDE INDUCES VASCULAR INJURY AND THROMBOSIS BY OXIDATIVE INJURY TO RED BLOOD CELLS
	-	THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
Sturk A.	-	INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS
	-	MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE
	-	SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
	-	CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY
	-	PLATELET MICROPARTICLES CONTAIN ACTIVE CASPASE 3
	-	RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS
	-	COAGULANT PROPERTIES OF MICROPARTICLE-ASSOCIATED FUSION PRODUCTS OF FULL LENGTH AND ALTERNATIVELY SPLICED HUMAN TISSUE FACTOR WITH GREEN FLUORESCENT PROTEIN
Sturm A.	-	PLATELET PROINFLAMMATORY AND HEMOSTATIC FUNCTIONS IN PATIENTS WITH CYSTIC FIBROSIS
	-	PLATELET-LEUKOCYTE INTERACTION: A CLEAR AGE DEPENDENCY
Stürzebecher U.	-	PRESERVATION OF IN VITRO FUNCTION OF PLATELETS STORED IN THE PRESENCE OF A SYNTHETIC DUAL INHIBITOR OF FACTOR XA AND THROMBIN
Stürzebecher J.	-	PRESERVATION OF IN VITRO FUNCTION OF PLATELETS STORED IN THE PRESENCE OF A SYNTHETIC DUAL INHIBITOR OF FACTOR XA AND THROMBIN
Su J.	-	A HETEROZYGOUS MUTATION OF GPIIB IN PATIENT WITH GLANZMANN THROMBASTHENIA
Su P.Y.	-	SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
Suarez L.R.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Suárez Gonzales L.	-	ACQUIRED HEMOPHILIA A IN A PATIENT WITH HYDATID DISEASE: A CASE REPORT
Subbi J.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Subirá D.	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
Subramanyam B.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Sucker C.	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Sudhakar V.	-	HEREDITARY DYSFUNCTIONAL FACTOR X IS THAT PASSOVOY FACTOR?
Suebsangad A.	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Suehisa E.	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
	-	IMPAIRED BINDING OF THROMBIN TO THROMBOMODULIN IS ASSOCIATED WITH RISK OF DEEP VEIN THROMBOSIS
	-	ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Sueiro A.	-	DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM
Sueishi K.	-	ROLE OF ANGIOPOIETIN(ANG)-1/TIE-2 SIGNALING PATHWAY FOR ANG-2 EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
	-	VEGF FUNCTION FOR UPREGULATION OF ENDOGENOUS PLGF EXPRESSION DURING FGF-2-MEDIATED THERAPEUTIC ANGIOGENESIS
Suga M.	-	PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
	-	THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
Sugawara K.	-	THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
	-	PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
Sugawara H.	-	HUMAN PROTEIN Z GENE EXPRESSION IS REGULATED BY HNF-4ALPHA AND SP1, INDEPENDENT OF WARFARIN AND VITAMIN K
	-	GAMMA-GLUTAMYL CARBOXYLASE-DEPENDENT SECRETION OF PROTEIN Z
Sugidachi A.	-	P2Y12 BLOCKADE BY PRASUGREL ACTIVE METABOLITE YIELDS COMPLETE INHIBITION OF P2Y12-MEDIATED AMPLIFICATION OF PLATELET RESPONSES
	-	COMPETITION BETWEEN REVERSIBLE AND IRREVERSIBLE P2Y12 ANTAGONISTS AND ITS INFLUENCE ON ADP-MEDIATED PLATELET ACTIVATION
	-	GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
	-	COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
	-	FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST
Sugimoto I.	-	IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
Suissa S.	-	WARFARIN USE AND THE DECREASED RISK OF PROSTATE CANCER
Sukhu K.	-	COMPARISON OF AN IMMUNO-TURBIDOMETRIC D-DIMER METHOD WITH AN ESTABLISHED ENZYME-LINKED FLUORESCENT D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLISM
Sukkar M.	-	INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
Sukumaran D.	-	HEREDITARY DYSFUNCTIONAL FACTOR X IS THAT PASSOVOY FACTOR?
Sullenger B.A.	-	DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
	-	ANTIDOTE REVERSAL OF A NOVEL ANTICOAGULANT DECREASES MORTALITY AND IMPROVES NEUROLOGICAL FUNCTION IN A MURINE MODEL OF SUBARACHNOID HEMORRHAGE
Sullivan M.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
Sullivan S.T.	-	REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B
Sullivan M.E.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Sulzer I.	-	A ROLE OF THE ADAMTS13 GENE IN ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sumarokov A.B.	-	MODULATION OF PLATELET REACTIVITY BY ERYTHROCYTES IN CORONARY ARTERY DISEASE PATIENTS TAKING ASPIRIN
	-	CIRCULATING PROPLATELETS IN HEALTHY SUBJECTS AND PATIENTS
Sumi H.	-	INCREASE IN NATTOKINASE ACTIVITY AND VITAMIN K2 CONTENT CAUSED BY DIPICOLINIC ACID
	-	ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
Sumi T.	-	MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Summerhayes R.	-	THE DIFFERENCES OF PLATELET RESPONSE TO SNAKE VENOMS: COMPARATIVE STUDY OF CHILDREN AND ADULTS
	-	AGE-RELATED REFERENCE RANGES FOR TAFI AND FIBRIN MONOMERS IN HEALTHY CHILDREN
	-	MONITORING OF ORAL ANTICOAGULANT THERAPY IN CHILDREN: COMPARISON OF COAGUCHEK XS WITH VENOUS INR
	-	ANTICOAGULANT EFFECT OF DANAPAROID, FONDAPARINUX, AND LEPIRUDIN IN CHILDREN COMPARED TO ADULTS
	-	UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
	-	ENDOGENOUS THROMBIN POTENTIAL: FUNCTIONAL ROLE OF ALPHA-2-MACROGLOBULIN
	-	IN VITRO PLATELET AGGREGATION OF PAPUAN SNAKE VENOMS
	-	REFERENCE VALUES FOR THROMBOELASTOGRAPHY IN HEALTHY CHILDREN
	-	CLINICAL EFFICACY OF ANTI-VENOM TREATMENT IN PAPUAN NEW GUINEA SNAKE-BITE PATIENTS
	-	AGE-RELATED REFERENCE RANGES FOR NEOPLASTINE R (PT) AND CEPHASCREEN (APTT) IN HEALTHY CHILDREN
	-	POTENTIAL USE OF AUTOMATED THROMBIN CLOTTING TIME (TCT) ASSAY FOR MONITORING UFH THERAPY
	-	UFH PHARMACOLOGY IN CHILDREN
Sumna E.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Sun J.	-	FACTOR IX CONCENTRATED IN THE JOINT SPACE PROTECTS HEMOPHILIA B MICE FROM BLEEDING-INDUCED JOINT DETERIORATION IN THE ABSENCE OF CIRCULATING FACTOR IX
Sun B.	-	EPITOPE MAPPING OF COLLAGEN BINDING SITE IN HUMAN GLYCOPROTEIN VI (GPVI)
Sun A.	-	ALTERATIONS OF HEMOSTATIC PARAMETERS IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sun Y.	-	EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
Sun J.	-	LOCAL INTRAARTICULAR EXPRESSION OF FACTOR IX FROM ADENO-ASSOCIATED VIRUS (AAV) VECTORS PREVENTS DEVELOPMENT OF HEMOPHILIC ARTHROPATHY
Sun Y.	-	SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Sun C.	-	PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN
Sun Y.	-	INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
Sun J.Z.	-	IDENTIFICATION OF ANERGY-RELATED GENES IN IDIOPATHIC THROMBOCYTOPENIC PURPURA USING MICROARRAY ANALYSIS
Sun J.	-	TISSUE FACTOR PROCOAGULANT ACTIVITY LEVELS IN HUMAN BLOOD ARE ELEVATED BY WARFARIN
Sunner T.	-	THROMBIN GENERATION ASSAY: CLINICAL USE IN MONITORING FVIII BYPASSING AGENT THERAPY DURING SURGERY IN A SEVERE HAEMOPHILIA A PATIENT WITH INHIBITOR
Superfine R.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Supryadkina T.	-	INTERRELATION BETWEEN GENETIC POLYMORPHISM OF HEMOSTATIC SYSTEM AND CORONARY HEART DISEASE IN PATIENTS WITH OBESITY UNDERWENT CORONARY ARTERY BYPASS GRAFTING
Surrenti C.	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
Susen S.	-	DRUG ELUTING STENTS: RESTENOSIS VERSUS THROMBOSIS ?
	-	METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES
Sushkova N.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Sutherland J.S.	-	EXTRA- AND INTRA-REACTIVE CENTRE LOOP ALTERATIONS TO ALPHA-1-PROTEINASE INHIBITOR ENHANCE ITS SPECIFIC INHIBITION OF THROMBIN
Suttnar J.	-	NEW HEREDITARY DYSFIBRINOGENEMIA AALPHA ASN106ASP ASSOCIATED WITH THROMBOSIS
Suvajdzic N.D.	-	EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION
Suvorova I.A.	-	LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS
Suwanawiboon B.	-	INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND
Suzuki H.	-	ULTRASTRUCTURAL ANALYSIS OF CULTURED MEGAKARYOCYTES GROWN FROM BONE MARROW MONONUCLEAR CELLS OF A NEWLY DIAGNOSED JAPANESE PATIENT WITH GRAY PLATELET SYNDROME
Suzuki T.	-	CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
	-	ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION
Suzuki Y.	-	THE EFFECTS OF BLOCKING P2Y12 RECEPTOR IN ARTEROSCLEROSIS PRODUCED BY MURINE ALLO-TRANSPALANTATION
Suzuki K.	-	REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Suzuki T.	-	FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
Suzuki K.	-	PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
Suzuki T.	-	CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Suzuki Y.	-	MODIFICATION BY PAI-1 OF SLOW EXOCYTOTIC DYNAMICS OF TISSUE PLASMINOGEN ACTIVATOR (TPA) AND ITS ACTIVITY ON VASCULAR ENDOTHELIAL CELLS (VECS)
Suzuki K.	-	LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
	-	REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
Suzuki A.	-	NEW LATEX-ENHANCED IMMUNOTURBIDIMETRY ASSAY WITH UNIQUE MONOCLONAL ANTIBODY TO SPECIFIC EPITOPES MEASURES SOLUBLE FIBRIN
Suzuki K.	-	IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
	-	CLUSTERING OF SURFACE-BOUND BETA2-GLYCOPROTEIN I
Suzuki T.	-	DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
Suzuki H.	-	INHIBITION OF CYTOSKELETAL ASSEMBLY BY CYTOCHALASIN D PREVENTS ENLARGEMENT OF RAFTS ACCOMPANIED BY GPVI ACCUMULATION IN COLLAGEN-STIMULATED PLATELETS
Suzuki-Inoue K.	-	G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN1 (GIT1) IS TYROSINE-PHOSPHORYLATED DOWNSTREAM OF INTEGRIN ALPHA IIB BETA3 IN PLATELETS
	-	THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
	-	PLATELET ADHESION TO LAMININ IS MEDIATED THROUGH VON WILLEBRAND FACTOR AND GLYCOPROTEIN IB UNDER HIGH SHEAR FLOW
	-	CLEC-2, A NOVEL PLATELET ACTIVATION RECEPTOR, IS INVOLVED IN PODOPLANIN-MEDIATED PLATELET ACTIVATION BY CANCER CELLS
Svae T.	-	THROMBIN GENERATION CAPACITY IS IMPAIRED IN METHYLENE-BLUE (MB) TREATED PLASMA UNITS COMPARED TO SINGLE-DONOR FFP, A PHARMACEUTICALLY LICENSED COAGULATION ACTIVE AND SOLVENT-DETERGENT (S/D) TREATED PLASMA PRODUCT AND A UNIVERSALLY APPLICABLE S/D-PLASMA UN
	-	PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
	-	VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
	-	A PHARMACEUTICALLY LICENSED SOLVENT/DETERGENT (S/D) TREATED PLASMA AND A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT IN TTP AND HUS: QUANTIFICATION OF ADAMTS13 AND FACTOR H LEVELS
	-	PRODUCT FEATURES OF THE NOVEL GENERATION VWF/FVIII CONCENTRATE IN A COMPARISON WITH FIRST GENERATION PRODUCTS
	-	PRION PROTEIN (PRPSC) REMOVAL BY CHROMATOGRAPHY PURIFICATION AND NANOFILTRATION OF FIXS AND PCC
	-	A BIOCHEMICAL COMPARISON OF A PHARMACEUTICALLY LICENSED S/D TREATED PLASMA WITH A UNIVERSALLY APPLICABLE DEVELOPMENT PRODUCT AND SINGLE-DONOR FFPS SUBJECTED TO METHYLENE-BLUE DYE AND WHITE-LIGHT TREATMENT
Svanas G.	-	ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE?
	-	ASSOCIATION OF IGG ANTI-OXLDL/B2GPI AND B2GPI-DEPENDENT ANTI-CARDIOLIPIN (ACL) ANTIBODIES WITH VASCULAR THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)
	-	REDUCTION OF DIABETES-RELATED LIPID OXIDATIVE STRESS BY STATIN THERAPY AS MONITORED BY SERUM OXIDIZED LDL/B2GPI COMPLEX LEVELS
Svensson P.J.	-	CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH
	-	CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH
Svensson M.	-	EFFECT OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 ON GLOMERULAR FILTRATION RATE IN ELDERLY HEALTHY SUBJECTS
Svirin P.	-	HAEMORRHAGES SYMPTOMS IN GIRL WITH FACTOR XII SEVERE DEFICIENCY
Svirin P.V.	-	MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
Svirin P.	-	EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
Svobodnik A.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
[Scaron]vorcová V.	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Swadzba J.	-	THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) DIAGNOSED USING UPDATED CLASSIFICATION CRITERIA
Swain M.	-	DO PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA HAVE ANTIBODIES TO ADAMTS-13
Swank J.	-	DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Swann B.	-	IDIOPATHIC FETAL GROWTH RESTRICTION (FGR) IS ASSOCIATED WITH DECREASED ANTICOAGULANT PROTEOGLYCAN DECORIN EXPRESSION IN HUMAN PLACENTA
Swanson C.E.	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
Swarup S.	-	STRUCTURE AND REGULATION OF A VENOM PROTHROMBIN ACTIVATOR GENE IN TROPIDECHIS CARINATUS SNAKE: A UNIQUE CIS-REGULATORY REGION RESPONSIBLE FOR THE ELEVATED EXPRESSION IN THE VENOM GLAND
Swavola J.	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Swiatkowska M.	-	INTERACTION AND FUNCTIONAL ASSOCIATION OF PROTEIN-DISULFIDE ISOMERASE WITH V3 INTEGRIN ON ENDOTHELIAL CELLS
Swystun L.L.	-	EFFECTS OF CHEMOTHERAPY AGENTS ON ENDOTHELIAL AND MONOCYTE HEMOSTASIS
Sychev D.	-	INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
Sydor W.J.	-	ASSOCIATION OF POLYMORPHIC SHORT TANDEM REPEAT -755 (CA)N IN THE HUMAN ALPHA2 INTEGRIN GENE PROMOTER WITH DEVELOPMENT AND EXTENT OF EARLY-ONSET CORONARY ARTERY DISEASE IN MEN: A CASE-CONTROL STUDY
Syed A.B.	-	LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
Syed A.	-	LACK OF PREDICTIVE VALUE OF HIGH SHEAR PLATELET FUNCTION IN A POPULATION BASED COHORT STUDY OF ACUTE VASCULAR EVENTS
Syrovets T.	-	THROMBIN INDUCES ACTIVATION OF MATURED DENDRITIC CELLS VIA RHO/ERK PATHWAYS
	-	THROMBIN STIMULATION AMPLIFIES MONOCYTIC/ENDOTHELIAL CELL CROSS-TALK AND SUBSEQUENT MCP-1 RELEASE THROUGH FRACTALKINE BINDING
	-	PLASMIN INDUCES PROINFLAMMATORY STIMULATION OF HUMAN MACROPHAGES VIA THE ANNEXIN A2 HETEROTETRAMER
Szabó T.	-	TWO NOVEL MISSENSE MUTATIONS (THR233MET AND TRP308LEU) IN THE FACTOR X GENE AND THEIR FUNCTIONAL CONSEQUENCES IN A PATIENT WITH SEVERE FACTOR X DEFICIENCY
Szabó I.	-	PRODUCTION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST THE B SUBUNIT OF FACTOR XIII THAT INHIBIT THE FORMATION OF HETEROTETRAMERIC COMPLEX OF A AND B SUBUNITS
Szabo G.	-	THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
	-	STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
Szanto T.	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
	-	THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA
Szarvas M.	-	POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Szasz R.	-	ANALYSIS OF SURFACE AND SOLUBLE L-SELECTIN IN RELATION TO FLOW CYTOMETRIC PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Szczeklik A.	-	ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
	-	ASSOCIATION OF POLYMORPHIC SHORT TANDEM REPEAT -755 (CA)N IN THE HUMAN ALPHA2 INTEGRIN GENE PROMOTER WITH DEVELOPMENT AND EXTENT OF EARLY-ONSET CORONARY ARTERY DISEASE IN MEN: A CASE-CONTROL STUDY
	-	THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN
	-	IMPROVEMENT OF THIOLACTONASE ACTIVITY OF PARAOXONASE 1 BY SIMVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
	-	THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) DIAGNOSED USING UPDATED CLASSIFICATION CRITERIA
	-	ANTITHROMBOTIC AND ANTI-PLATELET EFFECTS LIPID-LOWERING DRUGS, HOMOCYSTEINE AND N-METHYLNICOTYNAMIDE PLASMA LEVELS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
Szczepanik A.	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
Szekeres-Csiki K.	-	QUANTITATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION BY DENSITOMETRY
Széles G.	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
Sziller I.	-	THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
	-	STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
Szlam F.	-	HEMOSTATIC RESPONSES TO RECOMBINANT ACTIVATED FACTOR VII IN THE PRESENCE OF ANTITHROMBIN DEFICIENCY
Sztukowska M.	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
	-	POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
Szuldrzynski K.	-	REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
Szymanski J.	-	INTERACTION AND FUNCTIONAL ASSOCIATION OF PROTEIN-DISULFIDE ISOMERASE WITH V3 INTEGRIN ON ENDOTHELIAL CELLS